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ABSTRACT

Ex pr ess ive Writing and Br eas t Ca nc er:
Outcomes and Linguistic A na lyses

by

Kelly N. Hughes , Doctor of Philosoph y
Utah State U nivers ity, 2006

Majo r Professor: Dr. M. Scott DeBerard
Department: Psycholog y

This project examined the imp act of an exp ressive writing intervention as
com pared to a genera l hea lth in forma tion contro l on breast ca ncer patients '
postradia tion treatment. It further exami ned the co ntent of the exp ress ive wr itin g
narratives. T he samp le incl uded women who were comp let ing radiation treatment for
breast ca nce r at th e Huntsman Ca nce r Institut e and Ci ty of Hope hosp ita l. T he meas ur es
utili zed in this study were se lf-r eport instruments targeting psycho log ica l distress
(PANAS, JES) and genera l functioning (SIP), as we ll as demographic

qu est ionn a ires.

Results revealed the expressive w ritin g int erven tion sign ifica ntl y imp acted positive
affect over tim e. Furthermore, participants from both the treatment and control groups
evidenced improvements

in psychological

distress and general functionin g over time .

Linguistic ana lyses revealed participants ' use of positive affect words increased across
writing sessions, whereas the use of negative affect words and cognitive words did not

IV

change. Additionally, the use of past tense words decreased across writing sessions,
whereas the use of present tense words increased and the use of future tense remained
constant. The findings revealed from this study indicate that an expressive writing
intervention can positively impact breast cancer patients up to 1 year postradiation
treatment. Furthermore, the analysis of writing trends suggests that the use of positive
affect words, the decrease in use of past tense words, along with the increase of present
tense words across writing sessions, may be important linguistic components in positive
outcomes .
(180 pages)
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CHAPTER l
TNTRODUCTlON

Cancer is the second leading cause of death in women (Anderson & Smith,
2005), with breast cancer being the second lead ing cause of cancer-related deaths in

women (American Cancer Society, 2005). A total of 2,278,269 women were diagnosed
with breast cancer as of January of 2002 (Ries et al., 2005). Breast cancer is not only
highl y prevalent , but rates of breast cancer have also been steadily increasin g. [ncidence
rates of breast cancer increased 3.8% each year from 1980 to 1987 and 0.3 % each year
from 1987 to 2002 (Edwards et al., 2005). Ttis estimat ed that 212,920 women will be
new ly diagnos ed with breast cancer in 2006 (American Cancer Society, 2006).
Furthermore, the death rate i'rnrn breast ca11
ce 1· h:1s decreased 2.3°., each year l'rorn I 090
to 2002 (American Cancer Society, 2005). 1t is apparent that more women are being
diagnosed with breast cance r each year and more women arc also surviving this disease.
Receiving a cancer diagnosis , particularl y a brea st cancer diagno sis, and
enduring various treatment and recovery processes can be quite emotionall y distressing.
Individuals coping with breast cancer often find themselves experiencing high leve ls of
psychological distress (Palmer, Kagee , Coyne, & DeMichele , 2004) and decreased
quality oflife (Beriero, 2002; de Haes & Welvaari, 1985; for review see Moyer &
Salovey, 1996) . This psychological distress has been demonstrated to manifest in
depression, anxiety, and trauma-related syn1ptoms. For instance , 12-37% of breast
cancer patients have experienced a major depressive episode related to having cancer
(Love, Kissane, Bloch, & Clarke, 2002; Man zanera, Lafay , Papet , & Senon, 2003;
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Shou , Ekeberg, Ruland , Sandvik, & Kar esen, 2004). Furthermore, anxiety appear s to
affect a larger percentage of individuals with breast cancer than in the general
population (Hjerl, Andersen , Keiding, Mortensen , & Jorgensen , 2002) , with up to 48%
of breast canc er patients experienci ng severe anxiet y symptoms (Montazeri et al.,
2000) .
Many women further react to breast cancer as if it were a trauma . Resea rchers
have demonstrat ed that up to 32% of individua ls exper ience posttraum atic stress
disorder (PTSD) related to their breast cancer (Na idich & Motta , 2000) . Howeve r,
receiving a PTSD diagnosis in the context of breast cancer appears to vary according to
the type of asses mcnt and diagnostic too ls utilized (Kangas, Henry, & Bryant, 2002).
Furth ermore, it has been demonstrated that experiencing intrusion and avo idance
sympt oms related to one' s breast cancer is typica lly more comm on than meeting full
criteria for PTSD (Alter et al., 1996; Butl er, Koopman , C lasse n, & Spie gel, 1999 ;
Cordova et al., 1995; Green, Epstein, Krupni ck, & Rolland , 1997; Koopman ct al.,
2002; McGarvcy ct al., 1998). lndividual s who experience intru sion symptom s often
reex perience the traumatic event through thoughts or dreams , feel as if the event is
recurring , or experience distress or physiological reactivity when exposed to reminders
of the trauma . Avoidance symptoms are characteristic of avoiding thought s, feelings,
people, places, conversations, and other such reminders of the distressing event. It may
also be characterized by an inability to remember an important aspect of the trauma ,
anhedonia , feeling detachment from others , experi encing a restrict ed range of affect, or
having the sense of a shortened future (Ametican Psychiatric Association [APA] , 2000) .

-,
.)

These traumatic stress symptom s have been found to be further inversely related to
breast cancer patients' confidence in their ability to cope with the disease (Koopman et
al.).
Individuals who experience traum a typically feel stron g emotions (fear,
helplessness) and struggle to work throu gh the experience (i.e., avo id stimuli assoc iated
with the event, experience distressing thoughts about the event ; AP A, 2000) . Several
trauma-related theories exist that empha size the importance of process ing the
distress ing event in order to experience assimilation and poss ible positive increases in
psychologica l and physical functioning (Chemtob, Roitblat, Hamada, Carlson, &
Twcntyma n, 1988; Foa, Steketee, & Rothbaurn , 1989; Horow itz, 1986). Furthermore,
studies have demonstrated that the act of disclosing thoughts and emotions can be quite
benefic ial in reducing psychological distress. Specillcally, writing abo ut one's deepes t
thoughts and feelings (expressive writin g) related to a distressing event has been
assoc iated with decreased physician visits, improved immune functioning, and
impro ved psychological functioning (Francis & Pennebaker, 1992; Greenberg & Stone,
1992; Greenberg, Wortman, & Stone, 1996; Petrie, Fontanilla, Thomas, Booth, &
Pennebaker, 2004).
There has been a proli feration ofr esearch over the past decade in the area of
expressiv e writing as a treatment for traum a-related experiences. Research has
demonstrated that written emotional expression specifically related tQ a traumatic
experience can have a variety of positive effects on healthy population s (Dorrnelly &
Murra y, 1991; Francis & Pennebaker , 1992; Greenberg et al., 1996; Pennebaker,
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Co lder, & ShaqJ, 1990; Pennebaker, Kiecolt-Gl aser, & Glas er, 1988). However, few
studies have examined the effects of expre ssive writing on ill or diseased populations ,
with even fewer examining the effects of expressive writing with canc er patients,
particularl y breast cancer patients. Researchers have demonstrated expressive writing to
have positive effects (e.g., decrease in pain severity, better sleep qualit y, decrease in
avo idance behaviors) on individuals vvith prostate cancer and gynecolo gical cancers
(Rosenberg et al., 2002 ; Zakowski, Ramati , Morton , Johnson, & Flanigan, 2004) , and
metastatic renal cell carcinoma (de Moor et al., 2002). In term s of breast cancer, the
effects of expre ssive writing on patient outcomes vary across studies . Of the studies that
have c:rnmined breast cancer patients, one found the express ive writing intervention to
have pos itive e ffects on physica l health outcomes, but no effect on psychological
adju stment (Stanton et al., 2002). Another study exa mined the effect of expressive
writing on psycholo gical adjustm ent and side-effect severity , but found the intervention
to have no effec ts on these outcomes. Unfortunat ely, the authors did not examine
physica l health outcomes. Howeve r, they found indication s in the writing samples that
participant s found the writin g task to be helpful, sugges ting that the intervention may
have had an effect on outcomes (i.e., physical health) that were not examin ed in this
stud y (Walker , Nail, & Croyle , 1999). A third study examined the effect of journaling
on breast cancer patients while simultaneously participating in a 12-week support
group. Unfortunately, due to the simultaneous participation in a suppmi group, the
authors cou ld not extrapolate the unique effects of the expressive writing intervention
on outcome (Smith, Anderson-Hanley , Langrock , & Compas, 2005) .

)

Despite research demonstrating various positive effects of expressive writing
across a numb er of populations , very few studies have exam ined the key linguistic
components of express ive writing that may contr ibute to improved participant
outcomes. Uti lizing a computeri zed linguistic analysis program, researchers have shown
that patiicipants gain the most health benefits from express ive writing if their
compositions are made up of positive emotion words, negativ e emotion words, and
cognitive words connoting insight, meaning, or causa l thinking patterns (Pennebaker &
Francis, 1996; Pennebak er & Seagal, 1999). Curre ntly, researc h is mixed with regard to
the effect of the use of positive emotion words versus negative emotion words. For
instance, resea rch has demonstrated the use of negative emotion words to be assoc iated
with improved health outcomes (Low, Stanton, & Danoff-Burg, 2006; Pennebaker,
1993); whereas, the use of positive emo tion words is assoc iated with no hea lth
improvemen ts (Pennebaker). Others have found the opposite to be true, indicating the
use of negative emotion words to be either unrelated to or negatively related to health
outcomes and the use of positiv e emotion words to be associated with improv ements in
hea lth (Pennebaker & Francis; Pennebak er, Mayne, & Francis, 1997). Further research
is needed to detennine the specific linguist ic components related to improv ed outcomes.
In summary, receiving a breast cancer diagnosis and subsequentl y endu1ing
various treatment methods and recovery processes can be quite stressful and can result
in symptoms of depression, anxiety, and posttraumatic stress. Research has
demonstrated that the written disclosure of thoughts and emotions after a distressing
event can have positive health consequences. Currently, there is a paucit y of research
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exa mining the use of express ive writing interventions with breast cancer patients as well
as little research in the area of linguistic content analysis of expressive writin g
exe rcises . The purpos e of this project was to examin e the effect of an expressive writing
intervention on breast cancer patients, as well as examin e the content of the expressive
writing natn tives to identify critical components that may acco unt for the pos itive
effec ts of such writing in this population.
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CHAPTER II
REVIEW OF LITERATURE

Th e review of litera tur e outlines resea rch conducted on the ps yc holo g ica l
co nseq uence s (i.e., depress ion , anxiety, po sitive and nega ti ve affect, and traum a-related
sym ptoms) of rece iving a breast cancer diagnosis and enduring treatment for the
disease. The negative effects of experiencing a life-threatening

disease will be ex plor ed,

includin g theori es related to cognitive proc ess ing and emotional ex pressio n. Resea rch
pertaining to th e use of ex pr essive writin g, as a means of increas ing emotio na l
ex press ion , and its effec ts will also be outlined. F in ally, research exam inin g the specific
co mponents of express ive writing narrativ es that are relat ed to outcome will be
reviewed.

Breast Ca nce r and Psyc ho log ica l Distress

Receiving a breast ca nce r diagnosis and enduring ens uin g treatment and
recovery proc esses are assoc iated with a hi gh leve l of emotional distress. Women w ith
breast cancer m ay feel helpl ess and hop e less abo ut the future (Pettin ga le, 1984), have
low se lf-esteem (A nder so n & Johnson, 199 4) , and deve lop negati ve bod y ima ge
(Moyer, 1997). Women may furthe{ experience distress from fear of death (Vick berg,
2003), pain (Maunsell, Brisson, & Deschenes, 1993), fear of cancer recmTence
(Figueiredo, Fries, & Ingram, 2004; Vickberg) , and general unpredictabilit y of the
future (Voogt et al., 2005). This psychological distress is often manifested through
depression , anxiety , or generally low positive mood. Due to advances in detection and
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treatment, mor e and mor e women are surviving this pervasive disease and may strugg le
to cope with assoc iated physical and psycholog ical distress (Win go, Tong, & Bo lden,
1995) . The incr eased survival rate illustrat es the need for interven tions that target the
distress assoc iated with having and surviving breast cancer.

Depression and Anxiety

Several factors make diagnosin g depression in cancer pati ents diffi cult. First
and primaril y, depression can be difficult to accurately detect in this popul ation du e to
co mmonl y overlappin g physical symptom s of depression and cancer. Specificall y, the
Diagnostic ancl Stotistical Ma1111alof Mental D isorders -Fourth Editio n-Tex/ Revisio n

(DSM- IV-TR; Amer ican Psychiatric Assoc iation, 2000) cr iteria for a major depressive
episode includes physical symptom s such as !~1liguc,psyc homotor retardation

0 1·

agita tion, insomnia or hypersomnia, and weight loss or ga in. These sympt oms may also
be exper ienced as the result of having ca ncer and endurin g various cancer treatment s
(A merica n Ca ncer Soc iety, 2006). The follow ing preva lence studies that are discussed
did not spec ify whether they adjusted for phys ica l sym ptoms related to ca ncer versus
those related speci fica lly to depression.
Several studies have exa mined the preva lence of depression and anxiety in
general cancer patients (i.e., breast , prostate , lymphom a, neck; Berard, Boerm eester, &
Viljoen, 1998; Ciarame lla & Poli , 2001; Derogatis et al., 1983; Hotopf, Chidgey ,
Addington-Hall, & Ly, 2002; Ritterband & Spielberger , 2001) , with fewer studies
exa mining depression and anxiety rates in breast cancer patients specificall y. Available
resea rch has demonstrated that depression and anxiety rates in breast cancer patients
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(29-3 7%; Bur gess et al., 2005; Epping-Jordan et al., 1999; Love et al., 2002; Manzanera
et al., 2003; Shou et al., 2004) can be several times the rates found in the general
population (5-9%; American Psychiattic Association , 2000) and may be related to
mortality risk for breast cancer patients (Hjerl et al., 2003). However , varying rates of
psychological morbidit y are repo11edfor this population . Several factors contribute to
different rates of depress ion and anxiety in breast cancer patients, including stage of
treatment (diagnosis , treatment , recover y), type of treatment (lumpectomy ,
mastectomy), stage of breast cancer (early versus late stage cancer; see Table 1),
primary versus recunent breast cancer , age, and assessment measure utilized (EppingJordan et al.; Fallow field, Hall, Magu ire, & Baum, 1990; Hopwood, Howell, &
Maguir e, 199 1; Kissane et al., 2004 ; Montazeri et al., 2000; Pinder, Ramirez, Richards,
& Grego ry, l 99-+; Tibbs, 2003 ).

Researchers provid e conflicting findings (see Table 2) with regard to changes in
rates of depress ion and anxiety from the time breast cancer is diagno sed to the
posttreatment period (Shou et al., 2004; Tibbs , 2003). Depression in breast cancer
patients near the time of diagnos is ranges from 22-34% (Epping-Jordan et al., l 999;
Monta zeri et al., 2000; Shou et al.). Epping-Jordan and colleagues examined depression
and anxiety rates in breast cancer patients within an average of 11 days after being
diagnosed with cancer and again at 3- and 6-months postdiagnosis. They utilized the

Symptom Checklist-90 Revised (SCL-90R), a self-report measure of psychological
distress that includes a depression and anxiety scale. They found 34 % of breast cancer
patients experience depression symptoms in the clinical range based on the SCL-90R.

10

Table I

Breast Cancer Stage
Definiti on

Stage
Stage O

- earliest form of breast cancer
- cancer ce lls located within a duct that have not penetrated into surroundin g fatty tissue or
lobules
- ca ncer has not spread to distant sites

Stage I

- tumor s?c m and has not spread to axillary lymph nodes
- cancer has not spread to distant sites

Stage Tl

-

Stage lfl

- tumo r ~5c m and has spread to --+to 9 axillary lymph nodes or to interna l mamma ry nodes
- or. tumor > 5cm and has spread to I to 9 axillary lymph nodes or to internal mamm ary
nodes
- or. tumor has spread into the chest 11·all or skin and has spread to Oto 9 a:--illary lymp h
and may have spread to internal mammary nodes
- or, tumor is any size and has spread to either 10 or more ax illary lymph nodes, I or more
lymph nodes under or ove r the clavicle, or to internal mamm ary lymph nodes
- ca ncer has not spread to distant sites

Stage IV

- late stage breas t ca ncer
tumor can be any size and has spread to distant organs (bo ne. li\'l:r. lung) or
nodes far from the breasta

a A merica n

no tumor is in the breast, but it is in I to 3 axillary lymph nodes
or, tumor s? cm and has spread to l to 3 axillary lymph nodes
or, tumor is 2cm-5cm and has or has not spread to axillar y lymph nodes
or. tumor :25cm but has not grown into the chest wall or spread to axillary lymph nodes
ca ncer has not spread to distant sites

lO

lymph

Ca ncer Soc iety, 2006

Depression rat es decreased at 3 and 6 months postbreast cancer diagnosis with 29% and
- 26 % experiencing clinical range depression symptoms , respectively. At the time of
diagnosis , 40% noted significant anxiety symptoms, which decreased to 18% at 3
months , and then increased -to 21 % at 6 months postdiagnosis . Montazeri and colleagues
(2000) examined depression and anxiety in women 3 months after receiving a breast
cancer diagnosis utili zing the Hospital Anx iety and D epr ession Scal e (HADS). The

Table 2
Depression and Anxiety in Breast Cancer Parienzs
Authors

Year

Measures

Rares of distress

II

Depression, anxiety. or both:
1-5 years after diagnosis: 4 %, 25%, 23%, 22%, 15%, respectively
with breast cancer recurrence: 45%

Burgess et al.

2005

Structured Clinical
Interview for
DSM-Il!R (SCIO)

Cohen

2002

SCL-90R

80

Epping-Jordon et al.

1999

SCL-90R

110

3-lo/o clinical range depression symptoms at diagnosis, 29% at 3 months, 26% at 6 months
postdiagnosis
-l0% clinical range an:-.iety symptoms at diagnosis, 18% at 3 months, 21% at 6 months postdiagnosis

Fallowfield et al.

1990

"standard methods"

269

Depression:
Mastectomy: 29"" following surgery
27% at 3 months postsurgery
21% at I year postsurgery
Lumpectomy: 22% following surgery
15% ::it 3 months postsurgery
19% at I year postsurgery

Hopwood et al.

1991

HADS & RSCL

21-l

HADS: 9% depressed: 17% borderline
9% anxious: .5% borderline
9% depressed and anxious; I% borderline
f
RSCL 22% met cl 1n1cal cutof for psychological morbidity

Jenkins, May, &
Hughes

1991

CIDI, HAS,
MADRS

202

Recurrent breast cancer patients obtained significantly higher scores on anxiety and depression
subscales than non recurrent bre::ist cancer patients.

I 8% depressed
I .\'!lo anxious
14°10 both depressed and anxious

(table continues)

Authors

Year

Measures

Rates of distress

II

Kissane et al.

2004

MILP, HADS

Manzanera et al.

2003

HADS

Montazeri et al.

2000

HADS

151

3 months after diagnosis
22% depressed: 14% borderline depressive symptoms
48% anxious; 29 ° " border! me anxiety symptoms

Pinder et al.

1993

HADS

139

Ad,·anced stage breast cancer
12% depressed
19% anxious

503

Early stage breast G111cc1·
37%depressive disorders:
I 0% major depressive disorder, 2% dyshymic disorder, 25% adjustment disorder with
depressed or 1rn xed depressed/anxious mood
9'Yo anxiety disordc1-s:
2% general11cd anxiet) disorder, I% panic disorder, 2% PTSD,
4% adjustment disorder with anxious mood
Late stage breast c:mccr
32%depressivc disorders
7% major dcixessive disorder, 2% dysthymic disorder, 23% adjustment disorder with
depressed 01 1rnxed depressed/anxious mood
7 ° 0 anxiety disorders
2% generali1cd anxiety disorder, 0% panic disorder, I% PTSD,
4% adjustment disorder with anxious mood
Early stage cancer patients (89% breast cancer)
32% depressed
13% major depressive disorder, 19% adjustment disorders
30% anxious
15% agoraphobia, 9% generalized anxiety disorder, 6% panic disorder

(table continues)
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Authors

Year

Measures

Rates of distress

II

Shou et al.

2004

HADS

165

Tibbs

2003

CES-D

79

Time of diagnosis:
12% depressed
34% anxious
3 months after breast surgery:
6% depressed
2-1% anxious
year after breast surgery:
9% depressed
26% anxious
At radiation treatment complCllun:
29% depressed
2 weeks after radi:.111011 treatment completion:
23% depressed
6 weeks after radiation tre::llment completion:
28% depressed

\.,J
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HADS is a self-report meas ure w ith two subsca les (d epr ess ion and anx iety). Scores of
11 or mor e on eith er sub sca le indicate a significant case of depre ss ion or an x iety and a
sco re of 8 to l O indicat es depress ion or anxiety in the bo rd erlin e c lin ica l ran ge . They
found a lower depression rate in breast ca nce r pati ents, with 22% experiencing
significant depr ess iv e symptoms. T hey further found 14% were experiencing depr ess ive
symptoms in th e borderline clin ical range. With rega rd to anx iety, 48 % report ed
c lini ca lly signific ant symptoms and 29% reported ex periencin g bord erline sy mptoms.
Tibbs (2003) was int eres ted in the ps yc ho log ical adjustment o f wo m en after completing
radi ation tre atm ent for breast cancer. She measured depr ess ion throu gh the Center for

Epidemiologirn! Studies - Depressio n Scale (CES-D), a se lf-r epo rt mea sure of
depr ess ion that signifi es c lini ca lly signi Ii cant depre ss ive sy mptom s w hen a sco re o f 16
o r above is ob ta ined. S he found 29% o[ wo men expe rienced depres s io n at the encl or
trea tm ent , wh ich decreased at 2 weeks posttr ea tment (23%) and th en increas ed (28 %)
by the ir follow-up m edica l appo intm ent 6 wee ks posttr ea tment. Finall y, Shou and
co lleag ues (2004) report ed cha nges in dep ress ion and anxiety in women with breast
ca nce r at th e tim e of di ag nos is and 3 and 6 month s afte r surgery. Ut iliz ing the HADS ,
th ey found 12%, 6%, and 9% of wome n to ex perienc e c lini ca lly sign ificant depr ess ive
sy mptoms and 34%, 24% , and 26 experience sign ificant anx iety at diagnosis , 3 months
postsurgery,

and 6 months postsurgery , respectively .

Depression rates in breast cancer pati ents at the end of tre atment range from 2230% with most ev idenci ng a decrease in symptoms up to 1 year po stt rea tment
(Fallowfield

et a l., 1990; Tibbs , 2003). Tibbs examined the preval enc e of depr ess ion in
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patients who had completed surgery or radiation treatment and who were enter ing the
survival phase of breast cancer. She found depression to decrease 2 weeks after
treatment completion , but then increase almost 6 weeks later near patients' follow-up
doctor appointment. Approximately one third of participants experienced clinically
significant symptoms of depression at the end of radiation treatment as well as 6 weeks
later. Fallowfie ld and colleagues examined depression rates in women with breast
cancer immediately after completing breast surgery and 3 and 12 months after surgery.
They found women who underwent a mastectomy to evidence a downward trend in
depress ion rates, with 29% exper iencing depress ion after surgery, 27% at 3 months , and
21 % expe riencing depressive symptoms at I year postsurgery. With regard to women

who underwent a lumpectomy, depression rates decreased from the time immediatel y
following surgery (22%) to 3 months later ( I 5%) and then increased at l year
postsurgery ( 19%). The differences in depression rates between patients who underwent
mastectomy versus those who underwe nt lumpectomy were not found to be
sign ificantly different.
Regarding breast cancer stage, Kissane and col leagues (2004) found that early
stage (stage I or IT)and late or advanced stage (stage IV) breast cancer patients
experience similar rates of depression and anxiety, with adjustment disorders being the
most common diagnoses . They utilized the Monash Interview for Liaison Psychiatry

(MILP; a structured psychiatric interview for medically ill patients used to diagnose
mood, anxiety, and substance abuse disorders) and the HADS. They found 37% of early
stage patients to have a depressive disorder (9.6% major depressive disorder , 2.3%

l6
dysthymic disorder , 24.8% adj ustm ent disorder with depr esse d mood or mi xe d
depressed /anx ious mood) , and 9% w ith an anxiet y di so rd er (2% ge nera lized anxiety
disorder , I% panic di so rd er, 2% PTSD , 4% adjustment disord er with anxious mood)
approximately

3 months after breast surgery. With regard to late stage breast cancer

patients , 31 % had a depr essive disord er (6.5% major depressiv e disorder , 1.5%
dysthy mi c disorder, 23% adju stment disorder with depresse d mood or mixed
depressed / anx ious mood) , and 7% had an anx iety di so rder (2% ge nera lize d anx iety
disorder, I% PTSD , 4% adjustmen t di so rder wit h anx ious mood) 63 months after
receiving their ca ncer dia gno sis. Manzanera and colleagues (2003) found slightly lower
rate s of depression (32% total = l 3% major depressive disorder, 19% adjustment
disorders) in ea rly stag e cancer patient s (wome n w ith breast cancer repres ented 89% of
participants) and much higher rates of anxiety (30% tota l = l 5% ago raphobia , 9%
ge nera lize d anxiety di so rder, 6% pani c disorder) utili z ing the BAD S. Hop woo d and
co lleag ues ( l 99 l) found lower rat es of depression and simil ar rates of anxiety in
adva nced stage breast ca ncer patients. Based on sco res from the I-IADS, they found 9%
of women with advanced stage breast cancer expe rienced dep ression, 9% expe rienced
anxiety , and 9% experienced anxiety and depression (total of 27% w ith ps yc ho log ica l
m orb idit y). They found fewer women (22%) were identified as ex per iencing
psychological

morbidity based on scores from the Rott erdam Sy mptoms Checklist

(RSCL; a self-report measure of quality of life that includes a subscale pertaining to
psychological

symptoms). Finally , Pinder and colleagues (1993) repotied 12% of

advanced stage breast cancer patients to meet the clinical cutoff for significant
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depressive symptoms using the HADS and 19% with significant anxiety symptoms.
Breast cancer recurrence has also been assoc iated with depression and anxiety
symptoms in wom en (Cohen, 2002; Jenkins et al., 199 1). Cohen utilized SCL-90R to
examine psychological distress in breast cancer patients. She found individuals with a
recurrent diagnosis of breast cancer to have significantly higher scores on depression
and anxiety subscales of the SCL-90R as compared to women with a primar y and
localized (stage I or II) breast cancer diagno sis. Jenkins and colleagues found 46% of
women with recutTent breast cancer to experience psychological morbidity. They
specifically found participant s were "psychologically ill" with depression (18%),
anx iety ( 14%), or both depression and anx iety ( 14%). The identification of
psychological morbidity was based upon results from the Composite Interna tional
Diagnostic Interview (CLDl; structured assessment of psychological illness), the
Montgomery Asbe rg Dep ression Rati ng Scale (MADRS; a self-report measure of

depression), the Ha111ilto11
Anxiety Scale (HAS; a self-repo rt measure of anxiety), and
the Eyse nck P erso nality in vent ory (EPI; a self-report meas ure of personality
characteristics).
In addition, breast cancer patients who are older tend to experience lower levels
of depression and anxiety as compared to their younger counterparts (Kissane et al.,
2004; Pinder et al., 1994; Tibbs, 2003) . Specifically, women over the age of 55 have
been found to report fewer symptoms of depression than women under the age of 55
(Tibbs). Women with early stage breast cancer who are diagnosed with a depressive
disorder are also significantly younger on average (47.6 years) than women who are not
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depressed (53.2 years; Kissane et al.). In addition , being under the age of 50 has been
found to be associated with the development of a persistent (lastin g more than 6 weeks
after being diagnos ed with breast cancer) depressiv e and/or anxiety disorder (Pinder et
I

al.).

Positive and Negative Affec t

Depression and anxiety have historically been difficult to distinguish, as they are
highly comorbid and strongly associated with each other (Fawcett & Kravit z, 1983;
Murphy et al., 2004). They share common symptom s (e.g., irritability , sleep
disturbance, psychomotor agitation/ restlessness, fatigue, difficulty concentrating),
which contributes to their comorbidity (American Psychiatric Association , 2000). Selfreport measures of depression and anxiety have further been found to be highly
co1Telated (Dobson, 1985), demonstrating their sympt om overlap and difficult
discrim inability. Dobson found significant corre lations (range = .37-.86) between five
self-report measures of depression and four self-report measures of anx iety, suggest ing
the difficult y in discrimin ating between these two constructs. Some suggest depression
and anxiety lie on the same continuum (Angst & Dobler-M ikola, 1985) or represent
sub factors of a larger internalizing disord er model that includes all depressive (major
depressive episode, dysthymia) and anxiety (generali zed anxiety disorder , social phobi a,
simple phobia, agoraphobia, panic disorder) disorders (Krueger, 1999).
Research suggests that positive and negative affect represent the primary
dimensions of the majorit y of self-report measures of mood (Watson & Tellegen , 1985).
Positive affect is characteri zed by attention , activity, and interest level. High positive
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affect indicates overall enjoyable interaction with one's environment or excitement,
determination , high activity, and pride. Low positive affect reflects low energy and
fatigue. Overall , negative affect is associated with general distress , hostility , fear, guilt,
nervousness, and iJTitability (Watson, Clark, & Tellegen, 1988b).
Researchers have examined the relationship between positive and negative
affect and depression and anxiety and have found them to be correlated (Crawford &
Henr y, 2004; Watson et al., 1988b). Research demonstrates high negative affect to be
reflect ive of anxiety and the combination of high negative affect and low positive affect
to be related to depression (Boon & Peeters, 1999; Watson , Clark, & Carey, l 988a).
Spec ifically, Watson and colleagues found negative affect to be significantly correlated
with 55% (median r = .22) of anxiety symptoms (including symptom s of panic disorder,
phobias, and obsessive compulsive disorder) and 95% (median r

=

.33) of depressive

symptoms (both with correlations ranging from .20 to .57). They further found negative
affect to be significantly positively correlated with any depress ive diagnosis (.51) and
any anxiety diagnosis (.32) based on the Diagnostic int erview Schedule. Positive affect
was found to be significantly negatively corTelated with any depressive diagnosis (-.38),
but was not significantly related to any anxiety diagnosis except social phobia (-.23).
Crawfo rd and Henr y reported similar findings. They examined the relationship between
positive and negative affect and depression and anxiety utilizing the Depression
Anxiety and Stress Scales (DASS) and the Hospital Anxiety'.and Depression Scale
(BADS). Results indicated positive affect was more strongly negatively coJTelated with
depression (r = -.48 to -.52) than anxiety (r = -.30 to -.31) and negative affect was
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strongly positiv ely correlated with both depression (r = .44 to .60) and anxiety (r = .60
to .65). Jolly , Dyck, Kramer , and Wherry ( 1994) found additiona l evidence of a strong
negat ive relationship betwee n positive affec t and depress ion (r

=

-.61), a weaker

relationship between positive affect and anxiety (r = -.39) , and a strong positive
relationship between negative affect and depression (r = .77) and anxiety (r

=

.75).

Unlike the overlap between depression and anxiety, positive and negative affect
have been estab lished as distinct const ructs of psychological functionin g with relatively
little overlap (Watso n, Clark, & Carey, 1988a) . This finding lead to the deve lopment of
a self-repo rt measure (Pos itive and Negative Affect Scale; PANAS) that specifically
measures these constructs and is viewed as a more discrimin ate measure of affect ive
state (Wat son, Clark , & Tellegen, I 988b). The PANAS is a se lf-repor t measur e
consist ing of two subscales , pos itive affect (PA) and negative affect (NA), each made
up of IO items. The directions instruct individuals to respo nd to each item in a way that
indicate s how they have been feeling over a spec ified period of time (e.g., in the past
few days , over the past 2 weeks). Each item is rated on a Lickert sca le of 1 (not at all; 2:
a little; 3: moderately; 4: quite a bit) to 5 (extre mely; Watso n et al., 1988b). PA in the
general population ranges from 29. 1-36.2 and NA ranges from 14.8-22. 1, depending on
the time period spec ified in the instructions (e.g., how do you feel in the present
moment, how do you generally feel; Crawford & Henry , 2004; Watson et al., 1988b).
Since the development of the PANAS , research ers have set out to determine if
the PA and NA subscales of the PANAS are, in fact, independent constructs. During the
deve lopment and validation process of the PANAS , Watson and colleagues (l 988b)
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report ed a small ne ga ti ve corre lati on betw ee n PA and NA subscal es (r
over six occa s ion s of measurement).

= -.12 to -.23 ,

Schmukle, Eg loff , and Burns (2002) examined trait

("how do yo u fee l in genera l, that is, on average") and state (" ho w do you feel right
now , that is, at the present moment ") PA and NA in under gra duate universit y students.
They found that trait PA and
negatively corr e lated (r

=

A are ind epend ent, but state PA and NA are slightl y

-. 16 to -.27 over thr ee occasions of measurement) . Mehrabian

(1997) found a similar negative correlation (r

= -.12) between state PA and NA in an

und ergraduat e uni ve rsit y student population.

Th e highest corre lat ion betw ee n state PA

and NA was -.30, and was found in a ge nera l adu lt population in th e Un ited Kin gdom
(C rawfo rd & Henry , 2004). Ove ra ll, research has demonstrated

the PA and NA

sub sca les of th e PANAS to ev idence ver y littl e over lap and to repr ese nt relati ve ly
distinct co nstru cts (Schmukle et a l.; Watson et al., I 988b).
Few resea rch ers hav e exa mined PA and NA in indi viduals with cancer and
parti c ular ly in indi vidu a ls w ith breast cance r. However , so me emerge nt trend s are
evident. Voogt and co lleag ues (2005) exa min ed PA and NA in advanced stage cancer
patient s. They fo und PA to be low er in individuals w ith advanced stage cancer than
individuals in the genera l population. How eve r, they found NA to be comparable to that
of th e ge neral population. They suggest that psychological

distress characterized by

depression and anxiety may be largely related to low PA, as opposed to high NA as
found in psychiatric populations (Boon & Peeters, 1999). Walker, Nail, Larsen, Magill,
and Schwartz ( 1996) examined PA and NA in individuals with early stage, locali zed
breast or prostat e cancer at 20 months postradiation

treatment. They found these
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indi vidu a ls to have relati ve ly hi gh po siti ve affec t (M

= 38. 7) in com pariso n to the

ge nera l popul ation but comparable nega tive affect (M

=

17.0 ). fn ano ther stud y with

stage I or II br eas t ca nc er pati ents , Walker and co lleag ues (1999) found simil ar leve ls of
positiv e (M

= 36 .6)

and negative affect (M

in wo m en w ith breast cancer , Andrykowski

= 17.7).

Wh en examining the qu a lity of life

and colleagues ( 1996) found m ean po sitive

affect leve ls (3 3.6) to be relatively low er , but consistent w ith the ge neral popul at ion
(C rawford & H enr y, 2004; Watson et al., 1988 b) .

Trcwnw-Related Symptoms
The re has bee n a pro Ii feratio n of resea rch in the area of PTSD in br eas t ca ncer
pati ents particularly sinc e th e DSM- J V-TR (APA, 2000) added life-thr eateni ng illn ess as
a poss ible strcsso r that could result in suffi c ient trauma to lead to a PT S D dia gnos is. In
o rd er to obtain a di ag no sis of PTSD , one must hav e bee n ex po se d to a traumatic eve nt
th at invo lved act ua l or thr ea tened death , injury , or thr ea t to one's ph ys ica l \\'ClI-being,
and the indi vidu al's response must be characterized

by he lpl ess ness, fear , or horror.

Dia gnos tic crit eria for PTSD further requir es the ex perience of at leas t one intru sion
sy mpt om (i.e ., rec urrent distr ess ing thou ghts, ima ges , or percept io ns, rec urr ent dreams ,
feeling or behav ing as if the eve nt were recurring, distr ess when ex pos ed to reminders
of th e eve nt , ph ysiological reactivity when exposed to reminders of the event), at leas t
three avoidance syrnptoms (i .e., avoidance of thoughts , feelings, or conversations
related to the event, avoidance of activities, places , or people that serve as reminders of
th e event, inability to remember an important part of the eve nt, decreased int erest in
ac tiv iti es, feeling detached or estranged from others, ex periencing a decreased range of
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affect, feeling as if one's future is shortened), and at lea st two symptoms of
hyperaro usal (i.e ., trouble fall ing or staying asleep , in-itabilit y, difficu lty concentrating ,
hyper vigilance , ex aggerated start le response). Furthermore , these symptoms must elicit
signific ant distress in one's socia l, occupational, or -other area of functioning and must
last for mor e than 1 month (AP A, 2000).
Despite having established relatively agreed upon criteria for PTSD, rates of this
disorder in individuals with breast cancer tend to vary great ly depending on several
factors, includin g which diagno stic tool is utili ze d. Kangas and coll eag ues (2002)
co nduct ed a rev iew of literature on studies of cancer-related

PTSD , including studi es

spec ifica lly exa minin g br eas t cancer pati ents. The rev iew of brea st ca ncer studies wi 11·
be discussed here. Th e majorit y of studi es utili ze d a cross-sectiona l des ign and
exa min ed pati ents 2 month s to 12 yea rs po stprimar y trea tm ent for breas t cancer. Kang as
and co lleag ue s reported rate s of PTSD to vary accordin g to diagno stic instrum ent
utili zed. Resea rchers us ing the PTSD C lini ca l [ntervi ew for DSM-IV (SCID) found
incidence rates ranging from 0-9% (Andrykowski,

Cordova, Studts , & Miller , 1998 ;

Mund y et al. , 2000; Palmer et al., 2004). Those utili z ing the cut-off method (score of at
least 50) with the PTSD Check list C ivi lian Version (PCL-C), a self-report measure of
PTSD , found incidence rates ranging from 5-12% (Andrykowski
Andrykowski

& Cordova, 1998;

et al., 1998; Cordova et al., 1995; Jacobsen et al., 1998) , whereas those

utili zing the symptom cluster method (focuses on the required number of specific
symptoms) with the PCL-C found incidence to range from 6-19% (Andrykowski &
Cordova , 1998 ; Andrykowski et al. , 1998; Jacobsen et al.). Higher rates of PTSD (14%-
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32%) were found in indi vidual s with br eas t cancer when using the C linician
Administered

PTSD Scale - Structured lnt erview (CAPS-I; Naidich & Motta , 2000;

Pitman et al., 200 1). Incid ence rat es of PTSD also appear to be higher in individuals
w ith middl e- to advanced-sta ge (stage II-IV) breast cancer (Jacobsen et al.) as compared
to ea rly- to middle-stage (stage 1-JIIA) br eas t cancer (Andrykowski

& Cor do va, 1998;

And rykowski et a l., 199 8; Co rdo va et al. , 1995) . Other research ers found low er rates of
PTSD (4%) in br eas t cancer pati ents when using the SCID and further found younger
wo m en to be mor e like ly to res pond to their br east cancer diagnosis w ith inten se
he lpl ess ness, fear, o r horror (Pa lmer et a l., 2004).
Kangas and co lleag ues (2002) summ arized seve ral st udi es that exa min ed
intru sion and avoida nce sy mpt oms in br eas t ca nc er pati ents utili z ing the Imp act of
Eve nt s Sca le (!ES). The I ES is a se lf-report meas ur e of subj ec tiv e di stress that
spec ifica lly exa min es the ex peri ence of intru sive thou ghts or emotions("!

thought about

it w hen I didn ' t mea n to"; " An y remind er brou ght bac k fee lings abo ut it") and
avo idance beha vior s (" I tried to remove it from my m emo ry"; " l tri ed not to talk abo ut
it") in re latio n to a specific stresso r, lik e br east ca nc er. Ov erall , 5-52 % of br east cancer
patients evi denced high (score ~O) intrusion and avoidance symptoms (Butler et al.,
1999 ; Tjems land , Soreide , & Malt, l 996a , l 996b, 1998) . Furthermore , resea rch ers have
fou nd subclinic a l ( ex periencing symptoms of PTSD consistent with two of the three
symptom categories - intrusion , avoidance, hyperarousal)
breast cancer patients (Andrykowski

rates of PTSD in 5-13 % of

& Cordova, 1998; Andrykowski et al., 1998).

Koopman and colleagues (2002) examined intrusion and avoidance symptoms in
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stage l to III breast cancer patients who had received their breas t cancer diagnosis
within the past year. They found 12% scored in the clinica l range (score 220) on the
intru sion subscale and 27% scored in the clinical range on the avoidance subscale of the

lES .
Wide variation has been noted in incidence rates of breast cancer-related PTSD .
This variation appears to be influenced by a numb er of methodol ogical factors,
including the use of cross-sectional versus longitud inal study designs, the use of
di fferent assessme nt measures (structured interviews versus self-report), and the use of
retrospective data (Kangas et al., 2002). Participant factors also seem to influ ence rates
of PTSD in this population, including stage of breast cancer (Jacobse n et al., 1998), age,
and mar ital stat us (Tjerns land et al., l 996a). It is importan t to note that resea rch has
demons trated prev ious Iife stresso rs to increase the likelihood of deve loping trauma
symptoms related to a current traumatic event, whether that traumatic event be the
diagnos is of breast cancer (Ba ider, De-No ur, & Atara, 1997) or othe r traumatic event
(U llman & Siege l, 1994), which may further compl icate this clinica l picture.
It is apparent that many individuals with breast cancer evidence trauma-related
symptoms (i.e., intrusion, avo idance) at least at a subsyndrom al yet significant level. It
seems that the confounding factors related to determinin g whether a woman has actual
breast cancer-related PTSD are outweighed by the overwh elming finding that many
wom en with this disease experience significant trauma-related distress and could benefit
from intervention.
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Concfusio11s: Psyc hologi cal Distress
and Breas t Cance r

Research has demonstrated that breast cancer patients often experience
significant psychological distress throughout their expe1ience with cancer. Many
women with breast cancer experience significant related psychological distres s,
including depression , anxiety , PTSD, low PA, and intrusion and avoidance symptoms .
Rates of psychological distress vary according to various methodological (e.g.,
assessment measure used, cross-sectional versus longitudinal data) and particip ant
factors (e.g., breast cancer stage, primary versus recurrent breast cancer, type of cancer
treatment, age, marital status). Additionall y, researchers have explored alternative ways
to describe and measure psychological distress that avo ids the necess ity of a disease or
illness label, spec ificall y through the exa mination ofposi ti\C and ncgati\e affect (i c ..
PANAS) and trauma-related symptoms (i.e., intrusion , avo idance). It is obvious that a
large number of individuals diagnosed with breast cancer often struggle with significant
leve ls of distress at various times after disease diagnos is, treatment, and recovery.
Therefore, psycho logical interventions to help alleviate such distress in breast cancer
survivors are warranted .

Disclosure

Theoretical Implications

Disclosure refers to the act of expressing thoughts and emotions , which can
occur through verbal (talking) or nonverbal (e.g., writing) means. Several theories exist
to help explain changes that can occur during the disclosure process, which help
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indi vidu a ls to bet ter cope w ith ps yc ho log ica l dist ress, includin g traumatic ex periences.
Most th eo ries depict distressing or traumatic ex peri enc es as being incongruent with a
pe rso n 's schema or cognitive repres entation of safety and well-being (Hollon & Kriss ,
1984 ; Horowit z, 1986). Some postulate that a fear network or traumatic memor y
network is formed as a res ult of the distr ess ing eve nt (Cr ea m er, Bur gess, & P att iso n,
1992; Foa et a l., 1989). The trauma ma y furth er challenge the indi vidual 's view of the
self and /or of the world ( e.g., good thin gs happ en to goo d peopl e and bad things happ en
to bad peopl e, the world is a ju st place) leav ing one in a ge neral state of conflict with no
wa y of making se nse of or und erstandin g the distressing eve nt (Resick & Schnicke ,
1996). To optim ize hea lth and we ll-b e ing, the individual mu st proce ss th e trauma tic
expe rie nce in order to ass imil ate it into one's ex istin g cog nitiv e schemata. Pr eex istin g
sc hemata mu st also be modified to accom moda te th e inco ngruent in form at ion acc ru ed
from processin g th e distressin g ex perience (Chemtob et a l., 1988 ; Foa et al. ; Horowit z).
fn orde r to adeq uate ly proc ess and make se nse of s uc h a distress ing and cog niti ve ly
inco ngru ent eve nt, one mu st express tho ughts and em otions re lated to the eve nt
(Ne meroff et al., 2006). Foa and Jayco x ( 1999) found that negat ive though ts and the
tend ency to avo id thoughts and emotion s re lated to a trauma is common imm ediately
fo llo w ing a traum atic event. However, individuals who continue to avoid their traumarelated thoughts and emotions are at higher risk to developing PTSD . The active
concealment of distressing personal infonnation

from.nthers has also been found to be

corre lated with anxiety and depression (Ichiyama et al., 1993; Larson & Chastain,
1990). Conversely, the expression of one's thoughts and emotions related to a traumatic
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experience has been found to be physica lly and psycholog ically beneficial (Frisina,
Borod, & Lepore, 2004; Smyth, 1998).
Pennebaker and Beall (1986) posited a theory that relates inhibiti on to
physiological and disease processes. Inhibition is defined as the failure to talk, write, or
think about a personally distressing event. They discuss the inhibition of behaviors ,
thoughts, and feelings as physiologically taxing the body . The physiological demands
that inhibition places on the body can exert cumulativ e stress over time. The resultant
physiologica l stress can increase the likelihood o f deve loping a stress-related disease
(see Selye, 1978). Research has since support ed this inhibition theory. Specifically,
inhibiting one's thoughts and emotions can have immediate physiolog ica l effects on the
body by increas ing autonomic activity as measured by skin condu ctance leve ls and
heart rate (Hughes, Uhlmann, & Pennebaker, 1994). Furthermore, it has been associated
with more long-term cumulative effects, such as negative hea lth consequences (e.g.,
increases in physician visits, increased illness; Pen_nebaker, 1999; Pennebaker &
Susman, 1988), decreased immun e functioning (Pennebaker et al., 1988; Petrie, Booth,
& Pennebaker , 1998; Petrie et al., 2004), increased psychological distress (Bryant,

Moulds, Guthr ie, Dang, & Nixon, 2003; Donnelly & Murra y, 199 1; Foa, Rothbaum,
Riggs, & Murdock, 199 1), neopla stic disease (Jamner, Schwart z, & Leigh, 1988), and
poor disease cours e in cancer patients (Epping-Jordan , Campas , & Howell , 1994;
I ensen , 1987). The converse has also received support as disclosure has been associated
with improved health as well as a reduction in ruminations (Pennebaker & Susman) .
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Disclosure and Br eas t Cancer: Patt erns
and Effects

Few studies have examined disclosure patterns in breast cancer patients, but the
available research sheds some light on expression tendencies in this population.
Henderson , Davison , Pennebaker , Gatchel, and Baum (2002) specifica lly exam ined
degree of disclosure (not at all, a little, somewhat, very much) related to one's breast
cancer experience. They found that the majority of women discussed their disease at
least somewhat, but 15-23% disclosed only a little with family members, medical
personnel, or friends . Some breast cancer patients did not discuss their diseas e at all
with family (8%), medical personnel (6%) , or friends (8%). With regard to desire to
discuss their breast cancer, more than half indicated at least a moderat e desire.
Howeve r, 19~~>indicated not wanting to talk about their expe rience at all and 12%
wanting at least somewhat to keep their breast cancer a secret.
Stanton and colleagues (2000) assessed the predictive power of emotionall y
expressive coping on psychologica l and physical adju stment to breast cancer. They
examined stage I and II breast cancer patient s (N ==92) at an average of20 weeks
postbreast cancer treatment (i.e., surgery, chemotherapy, radiation). Data were again
collected 3 months later. Outcome measures utilized included the COPE (coping skills
related to having breast cancer, including avoidance behaviors), the Hope Scale
(behaviors related to goals), FACT (health related quality of life), POMS (psychological
distress, vigor), perceived health , and number of medical visits. Participants , who
reported coping by expressing their cancer-related emotions, evidenced fewer medical
appointme nts, an increase in perceived physical health and vigor (POMS), and a
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decrease in distress as compared to participants who reported low emotional expression.
Furthem1ore, for individuals who indicated having receptive social support, emotionally
expressive coping was related to increased quality of life (FACT). Howev er, individual s
who expressed an avoidant coping style evidenced an increase in distress and a decrease
in positive emotion at the 3-month follow-up .
Other researchers were interested in the effects of the inhibition of emotional
expression in individuals with breast cancer. Servaes, Yin gerhoets , Vreugdenhil,
Keuning, and Broekhuijsen (1999) examined potential diff erences in the inhibition of
emotional expression between breast cancer patients and healthy controls. They found
that breast cancer patients exhibit greater emot iona l constraint and ambiva lence about
emo tional express ion than contro ls. However, breast cancer patients did not differ trom
controls on their willingness to talk with others about their emo tions, their overall
propensity to express emotions, and alexithymia. lwamitsu , Shimoda, Abe, Kodama,
and Okawa (2003) specifically studied the effec t of emot ional inhibition (i.e., failure to
express negative emotions) on overall distress leve l. They found that the inhibition of
negative emotions, as meas ured pre- and postbr east cancer diagnosis, was related to an
increase in emotional distress (e.g., anxiety, depression) after being diagnosed with
breast cancer. It appears that individuals who have a tendency to restrain emotional
expression, experience higher levels of distress when diagnosed with breast cancer as
compared to individuals who express their-emotions. Additionally, the inhibition of
negative affect and an overall repressive personality style have also been related to the
spread of breast cancer (Jensen, 1987). Finally , others have found high negative
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affectiv ity and high emoti onal co nstraint to pr edi ct sho rtene d survi va l tim e in recrnTent
br eas t cancer pati en ts (Weihs, Enrig ht , Simmens, & R e iss, 2000).
Many women with br eas t cancer appear to ex pr ess thoughts and emotions
related to their diseas e experience (Henderson et al, 2002). How eve r, some women do
not ex press th emse lves and act ive ly inhibit negative em otions (He nd erson et al.;
Iwamitsu et al., 2003; Weihs et a l., 2000). Not disclosing one's thoughts and feelings
related to their breast cancer experience has been demonstrated to have deleterious
effects on indi vidu als and has spec ifica lly been associated with the spread of cancer and
with an ea rlier death (Jensen , 1987; Weihs et al.). Converse ly, the ac t of expressing
one's thoughts and emotion s related to their ex per ience of cancer has been
demons trated to have po s itiv e physica l and emotional consequences

(de Moor et al.,

2002; Low et al., 2006; Rosenbe rg et al., 2002; Stanton ct al., 2002; Walker et al., 1999;
Zakowski et a l., 2004). The follow ing o utlin es litera tur e perta inin g to the effects of
ex press ing one's thou ghts and emotions w ithin the context of express ive w ritin g.

Expressive Writing

Over th e past 20 yea rs, research examinin g th e effec ts of di sc losure through
express ive writ ing as a treatme nt for distressing ex perie nc es ha s proli fera ted .
Pennebaker and Beall (1986) were pioneers in this area. They developed an expressive
writing research paradigm that many researchers have.utilized ( e.g., de Moor et al.,
2002; Norman, Lumley, Dooley , & Diamond , 2004; Petrie et al., 1998; Rosenberg et
al. , 2002). First , participants are random ly assigned to either an expressive writing
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group (express deepest thoughts and feelings related to the traum a) or a control
condition (write about facts surroundin g a trauma or trivial subjects). Participants in the
expressive writing group are then instructed to write for a relativ ely short period of time
(i.e., 20 to 30 minutes) for 3 to 4 days. They are instructed to write about an
experienced traumatic or "t ragic emotional event" (Petrie et al.). Other studies have
instructed participants to wr ite about a specific distr ess ing experience such as chronic
pelvic pain (No nn an et al., 2004) or cancer (Rosenberg et al., 2002). Since Pennebaker
developed this express ive writing paradigm, man y subsequent res earchers have
examin ed its effec ts on both healthy populations and populations with either acute or
chronic illnesses (e.g., cancer , rheumato id arthri tis). While this review of literature will
include previous rc,·icws of studies involving health y participants, the primar y focus
w ill be on studies examining cance r patients.

Pre1•ious Re1·ie11·s of Erpr ess ive IVriting
Literatur e

Two systematic reviews of expressive writing literature have been publi shed.
One review examin ed express ive writing studies that utilized ph ysica lly and
psychologic ally healthy particip ants (Smyth, 1998), whereas the other examined studies
that utilized participants with physical or psychiatric disorders (Frisina et al., 2004).
Smyth ( 1998) conducted a systematic review of literature examining written
emotional expression and its effect on health. He specifically examined randomized
experim ents that utilized the written emotional expression intervention developed by
Pennebaker and Beall (1986). He further only included studies that utilized physicall y
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and psychologically healthy participants , and studies that instructed a treatment group to
write about traumatic events and a contro l group to write about innocuous events.
Additionally, studies included in the review utilized an outcome measure of health
(mental , physica l, general functioning) and provided sufficient infomrntion to calcu late
effect size. Smyth found 13 studies that met these criteria. He calculated an overa ll
effect size of d

=

.4 7, indicating a 23% improvement in overall health and well-being .

He further calculated an effect size for each outcome, which included reported health
(d = .42; i.e., health center visits, self-reported symptoms, upper respiratory illness),

psychological well-being (d = .66; i.e., positive and negative affect , anxiety, etc.),
physiological function ing (d = .68; i.e., T-he lper lymphocytes, blood pressure,
cholesterol , etc.) , genera l functionin g (d = .33; i.e., grade point average, absenteeism ,
reemplo yment, etc.) and health behaviors (d = .03; i.e., alcohol/drug use, exercise,
sleeping habits, etc.). All outcome effect sizes were found to significant ly differ from
zero, with the exce ption of health behaviors. Several cova riates were examined.
Specifical ly, neither the numb er of writing sessions (I to 5) nor the length of each
writing session ( 15 to 30 minutes) were associated with the overall effec t size; however,
the period of time within which the writing session took place (1 to 28 days) was related
to the overall effect size, but was not specifically related to psychological wel l-being or
physiological functioning. Being asked to write about past, current, or past and current
traumas was not related to the overall effect size. However, higher mean psychological
well-being effect sizes were found for patiicipants who wrote about current traumas and
higher mean physio logical functioning effect sizes were found for participants who
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wrote about either past or CL!ffenttraumas as compared to those who wrote about past
traumas only. The percentage of male participants was also found to be positively
associated with the overall effect size, whereas age was not.
Frisina and colleagues (2004) conducted a meta-analysis of written emotional
disclosure with clinical populations. Inclusion criteria included utilizing partic ipants
with a physical or psychiatric illness, an experimental design , Pennebaker and Beall's
(1986) expressive writing task (or some close variant), a quantitative measur e of
physical health, mental health, health behaviors, or general functioning, and sufficient
data to calculate effect sizes. The authors found nine studies that met these criteria. An
overall effect size was ca lculated for each study and for each outcome type and then
averaged across studies and outcome types to yield a significan t overal l mean effect size
of d = .19, p < .05. Five of the nine studies utilized physical health outcome measures,
which produced an overall effect size of cl= .21, p = .01. Eight of the nine studies
utilized psychological health outcome measures , which produced a nonsignificant effec t
size of d

=

.07, p

= . l 7.

Despite not findin g a significant overall effect for psychological

outcome, specific mental health outcomes indicated participants evidenced
improvements in the areas of depression (Beck Depression Scale, Automatic Thoughts
Questionnaire , Symptom Checklist-90), anxiety (Perceived Stress Scale), mood
(PAN AS-Positive Affect, Profile of Mood States), and sleep quality (Pittsburg Sleep
Quality Index) ~
Based on the respective reviews, physically and psychologically healthy
individuals appeared to not only generally have benefited from writing about a
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traumatic or distressing experience, but also benefited specifically in reported health,
psychological well-being, and physiological and general functioning. Psychologicall y
and physicall y ill populations also significantly benefited from such an intervention but
to a marginal degree. They evidenced significant improvements in physical health, but
not in overall psychological well-being. The failure to find a significant effect on
psychological well-being may in part be due to the inclusion criteria the various studies
utilized. The studies that examined psychiatrically ill populations did not exclude
participants if they were participating in psychotherapy or taking medications for their
psychiatric illness. The simultaneous participation in other treatments made it difficult
to disentangle the uniqu e impact of the exp ress ive writing interve ntion on outcomes
(Frisina et al., 2004).

Expressive Writing with Cancer
Pop ulations

Research invo lving pariicipants with cancer will be exa min ed in more detail ,
followed by studies specifically o f breast cancer patient s.
Other cance rs. de Moor and colleagues (2002) exa mined the effects of

express ive writing on late stage (stage IV) metastatic renal cell carcinoma (kidn ey
cancer) patients as compared to a neutral wtiting control (N = 42) . The treatment group
was instructed to write about their deepest thoughts and feelings related to their cancer
during four writing sessions. The control group (neutral writing group) was instructed to
write about various health behaviors (i.e., diet , sleep, physical activity). Psychological
and behavioral adjustment were assessed , utilizing the Impact of Events Scale (IES;
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intrusive thoughts and avoidant behaviors), Perceived Stress Scale (PSS; self-reported
stress), Profile of Mood States (POMS; tension-anxiety , depression-dejection
ho stility , confus ion-bewilderment,

, anger-

vigor, fatigue), and the Pittsburg Sleep Quality Index

(PSQI; subjective sleep quality, sleep lat ency, sleep duration, sleep efficiency, sleep
disturbances, use of sleeping medication, daytime dysfunction).

Follow-up data were

co llect ed on the da y of the last writing session and at 4, 6, 8, and 10 weeks
posttreatment. The majority of participants were male (86%) and had an average age of
56. No differences between the treatment and control groups were found on
ps ychological adjustment measures of IES, the PSS , and the majority of the subscales
on the POMS with the exception of the vigor subs ca le on which the ex pr ess ive writing
group repo rted sig nifi ca ntl y higher levels of vigor. However, significant differences
were found between the treatment and control gro up on th e PSQl, with the treatment
group ex periencin g less sleep disturbance , better sleep quality, increased time spent
sleep ing, as wel l as less daytime dysfunction.
Rosenberg and co lleagues (2002) conducted an ex pre ss ive writing study with
prostat e cancer patients (N = 30). Participants were randomi ze d to either an expressive
writing disclosure group or a nondisclosure control group. The treatment group
similarly wrote on four different days for 20 to 30 minutes about either their experience
with cancer or other traumatic life experience. All participants were male and had a
mean age of 70. Outcome measures included the National Medical Care Utilization an.d
Expenditure Survey, immune function and disease markers (prostate-specific

antigen

[PSA] va lues , peripheral blood T-cell proliferation, serum cytokine levels) , Brief Pain
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Inventory (BPI), Medical Outcomes Study-Short Fom1-36 (MOS-SF-36),

Functional

Assessment of Cancer Therapy Scale-Prostate (FACT), Symptom Checklist-90 Revised
(SCL-90-R), Brief POMS, Rumination Scale, and the Ways of Coping-Cancer
Follow-up outcome data were collected at 3- and 6-months posttreatment.

Version.

Again , results

indicated no differences between treatment and control groups with regard to
psychological outcome measures (SCL-90-R, Brief POMS , Rumination Scale, Wa ys of
Coping-Cancer

Version), quality of life (MOS-SF-36, FACT), and disease and

immunocomp etence measures. However. results indicated a trend toward lower number
of health care contacts and reduced medication use for the treatment group.
Furthermore, level of pain severity remained unchanged over time for the treatment
group (mild pain), but worsened for the co ntrol gro up (from mild pain at baseline, to
mod erate pain at 3 months, to severe pain at 6-month follow-up).
Zakowski and colleagues (2004) examined the effect of written disclosure on
participants with prostate or gyneco logical cancers (uterine, ovarian, cervical). They
were specifically inter este d in determining whether the ex pressive writing intervention
would serve to buffer soc ial constraint effects on distress. They defined social constraint
as perceived insufficient social support that results in hesitation or unwillingness to
express thoughts and feelings to others as related to a stressful event, like cancer. They
argued that individuals with social constraints thus may not have the opportunity to
process distressing experiences. Participants were randomly assigned to either an
expressive writing condition (n = 62), where they wrote about their deepest thoughts
and feelings related to the cancer experience across 3 consecutive days, or to a control
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condition (n = 42), where they wrote about daily activities without expressing emotions
or opinions. Approximately

half of the participants were female (52%) and had a mean

age of 60. The researchers assessed changes in social constraint (Social Constraint
Scale) and psychological

distress (Brief Symptoms Inventory , IES). Follow-up data

were collected 6-months posttreatment.

Findings revealed no significant chan ges in

distress levels (BSI scores) or level of social constraint for the treatment group.
However , treatment group participants who reported high levels of social constraint at
baselin e exhibited distr ess levels (BSI scores) comparabl e to individuals with low leve ls
of social constraint at follow-up. Individuals in the control group , who reported high
leve ls of social con straint , subs equ entl y report ed high leve ls of di stre ss at the 6-month
foll ow-up . An a lyse s furth er indicated no e ffect o f ex pr ess ive writin g on intru s ive
thoughts. How ever, indi viduals in the treatm ent group reported relativ e ly fewer
avoidance behaviors than control participants at th e 6-month follow-up.

Breast cancer. Walk er and collea gues ( 1999) conducted a pilot stud y exa minin g
the effects of expres sive writing on breast canc er patients as compared to a usual care
control group (no writing). They were specificall y int erested in the psycho social effect s
of expressive writing, as well as determining if this intervention would have a do serelated effect , with more disclosure opportunities

leading to increased effect.

Participants had early stage breast cancer (stage I or II) and were in their last week of
radiation trnatment. Mean age was 54. Participants were randomly assigned to either
one of two expressive writing groups or a usual care control group (n = 16). One
expressive writing group was instructed to write about their deepest thoughts and
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feelings related to their cancer experience one time (11= 12), whereas the other
expressive writing group wrote about their experience on three consecutive days

(n = 16). Psychosocial adjustment was measured with the PANAS (state and trait
forms), the IES , and the SEC (Side Effect Severity Checklist). Follow-up psychological
functioning data were collected 1 week, 4 to 6 weeks, 4 months, and 7 months
postradiation treatment. Results indicated expressive writing intervention did not
significantly impact psychological adjustment (PA and NA, intrusion and avoidance
symptoms) of participants. The authors hypoth es ized that this may have been due to the
small sample size and thus, low statistical power. Despite having no effect on
psychological functioning outcomes, many participants indicat ed the expressive writing
expe rience to be he lpful both in their writings and at a follow-up int erview. Participants
spec ificall y commented on the writing providing them with a means to express
emotions they thought might be taxing for others to hear about, helping to sort out
patiicular co nc erns and identify prioritie s, and being ge nerally helpful.
Stanton and colleagues (2002) examined effects of an expressive writing
intervention (deepest thoughts and feelings related to breast cancer experience) as
compared to a benefit finding (positive aspects of breast cancer experience) and control
(facts about the cancer experience) condition. They utili zed participants (N = 60) who
had early stage breast cancer and were no more than 20 weeks postmedical treatment
(i.e., surgery, chemotherapy, radiotherapy). All three conditions entailed writing for 20
minutes across four writing sessions (within a 3-week time period), with the difference
being the topic about which the participants wrote (thoughts and feelings about breast

40
ca nc er ex perienc e, benefits of the cancer experience, and facts related to the
ex peri ence). Follow-up data were collected 1- and 3-months postintervention.

Analyses

revea led no significant effects on psychological outcomes (POMS, FACT) for any of
the thTee groups. The authors speculate that this may have been due to participants
reporting overall higher quality of life and lower levels of distress as compared to breas t
ca ncer patients in other studies. Significant differences between groups were ob tained
for ph ys ical health outcomes (negative somatic symptoms, number of medical v isits) .
Spec ifica lly, the exp ress ive writing gro up ev idenc ed a significantly fewer physical
sym ptoms (mean = 17), as well as had fewer medical appointments (mean = 0.40)
related to their breast cancer as compared to the benefit finding (ph ys ica l symp toms:
mean = 22; medical appointments: mean = .90) and co ntrol gro up s (p hysica l symptom s :
mean = 30; medical ap pointm ents: mea n = 2.20) at 3 months po sttreatmen t. Fina lly,
participants who wrote about their deepest thou ghts and feelings and indi ca ted low
ca ncer-rela ted avo idance expe rienced a decrease in distress. How eve r, those who
indi cated a high leve l of avoidance ev idenc ed a higher leve l of distress at I -month
follow-up. This trend pers isted thrnugh th e 3-month follow-up per iod.
Low and colleagues (2006) examined data from Stanton and colleagues (2002)
to determine the means by which such an expressive writing intervention was related to
decreased physical symptoms and medical appointments . They specifically analyzed
mediator effects (i.e., heart rate, postwriting mood) on group variables. Heart rate
habituation during the writing session was greatest for the expressive writing condition
(mean = 16.78 , SE= 1.52, p < .05) as compared to the benefit finding and control
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conditions. Fwihermore, within writing session heari rate habituation mediated the
effects of the expressive writing intervention on physical symptoms. Participant mood
immediately following expressive writing had no significant impact on the overall
group effect. The authors indicate these findings suggest the decrease in autonomic
nervous system arousal that occurred after engaging in an expressive writing exercise, is
related to the processing of emotions associated with

a difficult past experience.

Conclusio ns: Disclosure

According to two meta-analyses of related express ive writing literature, it
appears that expressive writing has sign ificant and meaningful effects on healthy
individuals as well as on physically and psychologica lly ill individuals who experienced
a distress ing e\·cnt. Positive effec ts were found for reported hea lth, psychological wellbeing, and physiological functioning for healthy participants. Spacing writing sessions
across a longer time period (i.e ., 1 week between each writ ing session versus 24 hours
between each session); being male seem to increase the magnitude of positive effects
for healthy individuals. Furthermore, significant positive overall effects for physical
health were found for physically and psychologically ill peop le.
The three studies located pertaining to the use of expressive writing with cancer
patients provides somewhat limited findings due to the relatively small sample sizes.
However, overall it appears that health outcomes (medical contacts, sleep, medication
use) are positively impacted by the expressive writing intervention and that
psychological outcomes are not impacted by the intervention. Thus it is clear that more
research in this area is needed.
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Content Analysis of Express ive Writing Essays

As discussed previously , expressive writing can have positi ve psychological and
health outcomes for health y populations and positive health outcomes for ill or diseas ed
populations. The next important question to examine is: what are the linguistic variables
of the expressive writing exerc ise that are related to improved outcom es? This question
was originally posited by Pe1mebaker (1993) who was interested in detem1ining why
expressive writing is related to positive health benefits . He arrived at this important
question only after first exam ining the topic about which par1icipants wrote. He found
that when instructin g participants to write about a distr essing eve nt, they differed not in
the topic they wrote about, but in the manner within which they wrote or expressed
themse lves. For exa mple, two of his study participant s both wrote about problems they
had with a roommate ; however, one merel y listed the roommate 's character flaws,
whereas the other participant exa mined conflict with the roommate in a self-reflect ive
mann er (Pennebaker). Other resea rchers have reported si111iIar differenc es, including the
finding that participants who express significant emotio n experience increased immune
function as compared to those who do not express emotion when disclosing (Esterling ,
Antoni, Kumar , & Schneide1man , 1990). Thus , Pe1mebaker was interested in
detem1ining to what degree specific words, people choose to use to express their
thoughts and feelings, help to induce positive benefits of disclosure.
Few studies have examined the linguistic content of expressive writing essays.
Furthermore the majority of studies that performed content analyses utilized health y
participants (Pennebaker, 1993; PenJ1ebaker & Francis , 1996; Pennebaker et al., 1997).
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One study examined participants with kidney cancer (de Moor et al., 2002), and two
examined participants with breast cancer (Low et al., 2006; Walker et al., 1999). The
most common linguistic content variables examined across studies, included negati ve
emotions (i.e., sad, anxious, angry), positive emotions (i.e., happy, relief, joy), and
cognition, which consists of insight , causal, and self-reflective words (i.e., reali ze,
understand, because).
Researchers utili zed the Linguistic Inquiry and Word Count program (LIWC;
Francis & PenJ1ebaker, 1993) , which was recently updated (Pennebaker, Francis, &
Booth, 2003), to analyze the linguistic content of expressive writing essays. The LIWC
was origina lly developed to exam ine wr itten or spoken passages from indi vid ual s who
had exper ienced a trauma or genera lly distressing event. [ti s a text analysis program
that processes many different categories of words including those related to emo tions
(positive and negative) and cognition (causal- and insight-related words). This pro gram
ana lyzes text by searc hin g for wo rds that are categorized w ithin its dictionary file. The
dictionary til e for the original LIWC program contained over 2,000 words or word
stems that made up 61 specific word categories (i.e., positiv e emotion words, cognitive
words). The program was designed to examine a text document and detem1ine the
percentage of words within selected language dimensions in relation to the entire text
document. The dictionary in the LIWC program was developed by compiling a list of
words from thesaurus, emotion-related questionnaires,

dictionaries , and groups of

judges. After compiling the set of words, a minimum of two judges must have confe1Ted
independently as to which word category (i.e., negative emotion words) each word
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should be plac ed. Th e words were then ex amin ed for a second time, and at least thr ee
new judges had to reach agreement on the inclusion of words within a broader category
(P enn ebak er & Francis , l 996). The purpose of using such a program to analy ze th e
linguistic content of ex pr ess ive writing essays related to a distressing event is to help
determin e if spec ific writing styles (e.g., using positiv e emotion words, cognitiv e
words) lead to impro ved outcomes.
Pen11ebaker (1993) examined the linguistic content of expressive writing essays
from thr ee pre vious studi es (Penn ebak er, 199 l , as cited in Penn ebak er, 1993;
Pennebaker et al., 1988 , 1990) in order to explore wh y writing can be advantageous.
Afte r analyz ing a numb er of diff erent ling uisti c dim ens ions, he found that participants
who ev idenced hea lth imp roveme nts utili ze d a large r proportion of nega tive emot ion
wo rd s (i. e., anxiety , sad ness) than positiv e emotion words as compared to particip ants
who did not impro ve . Pennebaker futiher found that th e participants who improved
ev idenced simil ar total numb ers of cog niti ve pro cess ing words as the partic ipant s who
did not impro ve. However , parti c ipants who impro ve d pro gresse d from using fewe r
cog niti ve processing words in th e first w ritin g sess ion to mor e cognitive pro cess ing
wo rd s by the las t writin g sess ion . Expressing nega tiv e emotion as well as evidencing
cognitive processing is consistent with most trauma theori es that suggest emotional
expression and cognitive processing, or assimpation of traumatic experiences, are
necessary to make sense of and positively cope with distressing events (Chemtob et al...,
1988 ; Foa et al. , 1989 ; Horowit z, 1986).
Pennebak er and Francis (1996) obtained some contrary conclusions to
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Penn ebak er 's prev ious finding s. Specifically, th ey found negative emotion words to be
unr e lated to changes in health outcomes. Furthermore, the use of positive emotion
words was relat ed to better hea lth outcomes. With regard to cognitive processing ,
similar results to Pennebaker (1993) were found with increased cognitive processing
across w riting sess ions leading to positive hea lth outcomes.
Pennebaker and colleagues (1997) reanal yzed data from six existing studies that
utili ze d langua ge va riabl es as health predictors. Participants
(Pennebaker

included college students

& Francis, 199 6; Pennebaker et al., 1988, 1990) , medical students (Petrie,

Booth , Pennebaker, Davison , & Thomas, 1995) , maximum-security

male inmates

(R ichards , Pennebaker, & Beall, 1995, as cited in Pennebaker et a l., 1997), and
unemployed male professionals
Buhrfeind, & Pennebaker,

w ho had been laid off from their jobs (Spera,

1994). The authors found the use of more nega tiv e emotion

words in relation to positive emotion words to be associated with negative outcomes.
This is in direct co nni ct w ith Pennebaker's

( 1993) ea rlie r findin gs. The authors further

found th e use of more positive emotion words

111 re lati on

to fewer nega tive words to be

related to better hea lth. This is similar to results Pennebake r and Francis obtained,
which indicated that the use of positive emotion words are related to better health
outcomes. A regression analysis using adjusted distress as the outcome revealed that
participants who reported greater distress at follow-up used more death-related

and

positive words and used fewer past tense verbs and unique words as compared to
participants

experiencing

less distress. With regard to cognition, the increased use of

cognitive processing words from the first day of writing to the last was associated with
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decrease d physician visits and reported physical symptoms , as we ll as impro ved grades
and gaining emplo yment.
de Moor and colleag ues (2002) exam ined the linguistic content of express ive
writing essays in participants with kidney cancer. Unfortunatel y, they did not provide
details of this analysis. The authors noted the expressive writing essays to be
sign ificantly different from control essays on 24 of 32 different word categories ,
includin g affective, cognitiv e, and socia l processing. Th ey provided no mor e
explan ation of findings.
Walker and co lleagues (1999) conducted the most app licab le experiment to the
curre nt project. They exam ined the linguistic content of narrati ves writte n by patients
with breast cancer. The authors did not comment on the relationship of linguistic
compon ents to outcome, as the expressive writing intervention was not found to be
significantly related to outcome. Howev er, the authors reported writing trends for the
exp ress ive writing treatment group. They computed paired r tests to assess change in the
percentage of words across various categories from the first writing sess ion to the third.
Walker and co lleagues found a significant increase in words related to general affect
and decreases in words pertaining to metaphysical concerns (death, religion) as well as
words related to body functions and states. They did not spec ificall y examine cognitive
processing words .
The most recent study to examine the linguistic content of expressive writing
narratives also utilized a breast cancer population . Low and colleagues (2006) examined
the linguistic content of narratives from participants who were either instructed to write
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about their deepest thoughts and feelings related to their breast cancer experience
(genera l disclosure) or write about the benefits of their cancer experience (benefit
finding). General writing trends included an increase in the use of positive emotion
words across writing sessions for both groups, a decrease in negative emotion words
across sessions for the general disclosure group , and greater use of cognitive words for
the general disclosure group as compared to the benefit finding group. They found no
significant changes in the use of cognitive words across writing sessions for either
treatment group.

Co11clusio11
s: L ing uistic Analyses
Due to the smal I number of studies and heterogeneous sample populations in
ary should be considered preli111in
ary. O,·era ll,
this area of research, the lo llo\\·i11gsu111111
studi es demonstrated the expression of negative and positive affectiv e words to lead to
better outcomes. Unfortunat ely, conflicting findings were found with rega rd to the
e ffect of the percent of negative words expressed in relation to the percent of positive
words expressed. Additionally , the increa sed use of cognitive words acro ss writing
sessions resulted in increased positive outcom es. This is the most con sistent finding
acros s studies. Cognitivel y proces sing the events of a trauma is thought to be necessary
for cognitive assimilation , understanding , and overcoming traumatic experiences
(Chemtob et al., 1988; Foa et al., 1989; Horowitz, 1986).

Summary and Objectives of the Current Project

Cunent literature indicates the diagnosis and treatment of breast cancer to be
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quite distressing for many women. Resea rch has further demonstrat ed expressive
writing to have positive effects for some healthy individuals who have experienced
distressing or traumatic events. Although limited, research suggests expressive writing
positively impacts physical health outcomes in women with breast cancer. Additionally,
resea rchers have begun to explore specific linguistic components of expressive writing
narratives that are related to positive outcomes. However, there is a relative dearth of
literature in the area of expressive writing in breast cancer patients , as well as linguistic
ana lyses of such writings. The current project examin ed the effec t of an expressive
writing intervention on breast cancer pati ents, as well as examined the content of the
exprcss i\'e writing narrati ves to identify critical components that may facilitate the
positive effects of such writing in this population. The following questions were
addressed by this project:
I. Does an expressive writing intervention impact positiv e affect, negative

affect , intrusion and avo idance symptoms , or genera l functioning as compared to a
genera l health information controJ?
2. What are the relationships between the use of positive wo rds, negative words,
cognit ive words, and verb tense across the three writing sessions with positive affect,
negative affect, intrusion and avoidance symptom s, and general functionin g?
3. Is perception of prior disclosure at baseline related to intrusion and avoidance
symptoms, positive affect , negative affect, or general functioning at baseline and
follow-up?
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CHAPTER Jil
METHOD

Data Collection

This study utilized a portion of an extant data set collected tlu-ough a grant from
the National Institute of Nursing Research (ROI NR0457l-02) at The University of
Utah awarded to Lillian M. Nail, R.N., Ph.D., principal investigator (Appendix A). The
or iginal study was a randomized clinical trial utilizing a three-group design. The
investigators were interested in determinin g the effectiveness of two primar y
interventions designed to facilitate the coping process follo,ving radiation therapy for
breast cancer . The concre te objective info1111ati
on interve ntion (not utilized in the
current project) intended to address side effects or symptoms and unexpec ted
experiences of breast cancer patients. Its aim was to improv e patients' confidence,
understan ding, and abi lity to app ly spec ific strategies and accurate expectat ions
regard ing side effects, symptom s, and experiences related to the completion of radiation
therapy. The expressive writing intervention (EW) addressed negati ve cancer-related
thoughts and emotions that are often inhibited. The aim of this intervention was to
reduce inhibition of cancer-related thought s and emotions through linguistic expression.
The concrete objective information and expressive writing interventions were derived
from self-regulation theory and designed to target postradiation treatment coping
processes in women with breast cancer. Specifically, the concrete objective information
intervention targeted instrnmental coping and the expressive writing intervention
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targeted emotional coping. The expressive writing intervention involv ed instructing
participants to write about their deepest thou ghts and feelings related to their cancer and
cancer treatment (Appendix B). They we re told to write for 30 minut es on three
different days over the following 5 days (e.g., write toda y, skip a day, and write on the
following two consecutive days).
The third treatment gro up, general health information (GHI), provided
inform ation to participants that might typicall y be offe red to patients by their health
care prov iders and \\·as conside red a treatmen t as usual control. This intervention
entail ed participants listening to a tape recording on the final day of their radiation
therapy (Appe ndi x C). They were further instructed to rcviC\\' a pamphlet that contained
the same informat ion as provid ed on the tape recording on the follow ing two clays. The
hea lth inform ation provided to participant s was obtained from common patient
education material s found in cancer treatment facilities. The inform ation spec ifically
included a description of changes in radiation treatment side effects that are often
experienced after the completion of such a treatment, thoughts and fee lings women
experience follow ing treatment , cancer resources, as we ll as posttr eatment medical
information. The description of side effect change s included info1111
ation about dry or
peeling skin , numbn ess, fatigue , hot flashes, and difficult y sleepin g. Inform ation related
to thoughts and feelings focused on a description of conunon patterns of thinking or
feeling , including thinking about cancer and cancer treatment when one did not intend
to, experiencing feelings about cancer and cancer treatment after encountering a
reminder or trigger , and feelings of dereali zation or emotional numbness. With regard to
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cancer resources , participants were provided contact information (i.e., telephone
numbers , int ernet add resses, street addresses) for the Amer ican Ca nc er Soc iety and
NCI, and were encouraged to access cancer info1111ation ti-trough local public libraries ,
bookstores , and librari es at co lleges and universities. They were also advised to write
down contact information for their radiation treatm ent facility and doctor , as well as the
spec ifics of their diseas e (i.e ., type of cancer, date of diagnosis, date treatment was
completed). Addit iona lly, the GHI group was provided w ith info1111ation about expected
follow-up doctor visits and hov,, to get the most o ut of those v isits. They were further
provided with genera l infonnation

on taking advantage of health insurance coverage

and how and where one co uld volunteer her time working with others who have cancer
if she so desired.
The primary goa ls of the c urrent proj ec t was to exami ne the effect iveness of
Pennebaker and Beal l's (1986) ex pressive writing int ervention with breast cancer
patients and to analy ze the I inguistic content of written narrati ves. The proj ect was
modeled after existing ex pressive writing literatur e that compared an ex pressiv e writing
treat ment group to eith er a benign writ ing group (e.g., write about facts of an event ,
objective ly describe an object or event; Booth , Petr ie, & Pennebaker,

1997; Pennebaker

& Beal , 1986; Pennebaker & Francis, 1996; Stanton et al., 2002) or treatment as usual ,
nonwriting control group (Richards, Beal, Seagal, & Pennebaker,

2000; Rosenberg et

al., 2002; Walker et al., 1999). Therefore, the-current project examined only two (EW
and GHI gro up s) of the original study's thr ee treatment groups. The rationale for
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exc luding the concrete objective infonnation treatment group was based on the premise
that it was outside of the scope of an expressive writing intervention study.
Patients completed baseline measures 1 week prior to their comp letion of
radiation therapy and were then randomi zed to either the concrete objective
information, EW, or GHI conditions. Instructions for the interventions were then
provided during the patients' final radiation therapy appointment.
In the original study, the decision to study the effects of this treatment
postrad iation therapy completion was made as a result of research indicat ing this can be
a stressfu l time for cancer patients. After completing cancer treatm ent, many individuals
hzive unexpected intrusive thoughts about their cancer expe rience, avoid reminders of
their cancer (Walker et al., 1996), and avo id thinkin g about their cancer (Jar rett,
Ramirez, Richards, & Weinman, 1992) . Fu rthermore, patients have indicated the often
more intense social suppoti that was present during their diagnosis and treatment
dec lines and fear of cancer recurrence increases (Maher, 1982). It was because of the
potential for experiencing stress that it was determined the postrad iation treatment
period would be well suited for such an intervent ion.

Participants

The target population for the study consisted of women receiving curative
radiation therapy for breast cancer. Participants were recruited from Huntsman Cancer
Institute in Salt Lake City, Utah, and City of Hope in Duarte, California. In order to
participate in the original study , participants were required to meet several criteria,
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including being at least 2 1 years of age, receiving curative radiation therapy for stage l ,
ll, or III breast cancer, being able to speak, read, and write English, being able to
engage in self-care activities independently, and having no known substance abuse
probl ems. Particip ants fu1iher could not at the time of the study be receiving psychiatric
services or have a history of cognitive deficit. Data collection took place from July 1998
through December 2000.
A total of 275 breast cancer patients were recruited for the original study and
randomized to one of the three treatment groups, concrete objective infom1ation, EW,
and GHI. The current project examined the EW treatment group (N = 89) as compared
to the GHf control group (N = 9 1). Baseline data for one GHI group participant was lost
due to researc h error. Therefore, this subject was dropped from all analyses, leaving 90
participants in the GHl control group (Figure !). Furthermore, 1-week follow-up
outcome data was not obtained from one treatment group particip ant, as a result of
being unable to contact that person, and from one control group participant for an
unknown reason. Follow-up data at 4 weeks, 6 months, and I year postradiation
treatment were not obtained for two EW group participants due to the participants
requesting to drop out of the study at the 4-week follow-up. One-year follow-up data
were also not obtain ed from seven EW group parti cipants (six due to inability to contact
them, one due to an unknown reason) and from two GHI group participants (due to
inability to contact them). Finally , two EW participants and one GHI group participant
were deceased by the I- year follow-up from cancer-related complications , which
precluded the collection of further data from those pariicipants.

Participants

EW =8 9

GHI = 90

Follow-Up
I week = 88
4 weeks= 87
6 months= 87
1 year= 78

Follow-Up
I week= 89
4 weeks= 90
6 months= 90
I year = 87

Figure 1. Particip ant profile graph depict s the participant profile from baseline tl1rough

the I- year follow-up.

Measures

Data were collected through seve ral self-report measur es. Participant s
spec ifica lly comp leted a genera l screening form, a demographic form, two measures
assess ing psychological distress , one measure of genera l functioning , and an assessment
of prior disclosure (Appendix D). The following outlines descriptions and psychometric
properties of each assess ment instrum ent as well as a description of the linguistic
analysis program utilized.

Participant Scre ening Form

The Participant Screening Form was made up of questions related to participant
inclusion criteria . Specific questions pertained to general contact information , breast
cancer diagnosis and treatment, primary language, psychiatric care, substance abuse,
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independence of self-care, living environment (i.e., institutional setting), and cognitive
functioning .

Demographic Data

General demographic data (e.g., age, ethnicit y, education level, marital status,
emplo yment) were obtained directly from participants through a demographic
question_naire. Information pertaining to their breast cancer (e.g., stage of disease) was
obtained from medical records.

Positive and NA Schedule
(PANAS)

The PANAS, as deve loped by Watson and colleagues (1988), is a 20-item
assessment that measures the principal dimensions of mood, and positive and NA. lt is
comp rised of two 10-item subscales, the PA subscale and the NA subscale. PA is
described as atten tive, interested , alert, exci ted, enthusiastic, inspired, proud ,
determined, stro ng, and active. NA is described as distressed, upset, host ile, irritab le,
scared, afraid, ashamed, guilty, nervous, and jitter y. High PA is characterized by
exci tement and high energy, whereas low PA is characterized by lethargy and sadness.
General negative mood states (e.g., anger, fear, guilt) reflect high NA, whereas
tranquility and calmness are associated with low NA. Validity and reliability have been
well established. Internal consistency for PA ranges from .86 to .90, and from .84 to .87
for NA, depending upon the time instruction utilized (i.e., right now, today, during the
past few days, during the past week, during the past year, in general or on average).
Convergent validity was high, such that the convergent correlations ranged from .89 to
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.95. Discriminant correlations were low (-0.02 to -0.18). External validity has also been
supported through significant correlations with other measures of psychological distress
(Beck Depression Inventory: PA = -.35, NA = .56; State-Trait Anxiety Inventory State
Anx iety Scale: PA= -.35, NA= .51). Additionally, the correlation between the two
PANAS subscales is low, indicatin g PA and NA share 1-5% of their variance (Watson
et al., 1988). This is a strong indication of the scales' relative independence.
Furthermo re, Watson and colleagues reported mean PA to range from 29. 1 to 36.2 and
A to range from 14.8 to 22. 1 depending upon the time period assessed (e.g ., today,
past few days, past year) . Participants in the present study were instructed to answer
questions on the PANAS according to how they had been feeling over the past few
days. The reliabilit y coefficient alpha of PA and NA of the pres ent data are .87 and .89.
respectivel y.

Si ck ness !111pact Pro.fil e (SIP)

The STP is a measure of sickness-related dys function and was develop ed for use
with individuals with acute and chronic illnesses (Bergner et al., 1976). The full version
of the SIP consists of 12 subsca les that address behaviors such as participation in socia l
activities and ability to comp lete activities of daily living. Research on women
receiving radiation therapy for breast cancer has demonstrated the subscales of home
management, mobility , recreation and pastimes, and work are the most relevant to
functional outcomes for this population (Graydon, 1988, 1994). In order to decrease the
burden of completing such a lengthy measure, only these four subscales were
administered to participants. Previous research has indicated that selecting specific
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subscales pertinent to disruption in functionin g related to a particular clinical situation
or to gender does not compromise vital data. Furthermore, the subscales themselves
retain adequate psychom etrics (Graydon , l 994; Johnson, 1996; Jolmson , Nail, Lauver,
King , & Keys, 1988;

ail, l 993; Nail, King, & Johnson , 1986). Participants in the

present study were also specificall y instruct ed to respond to items in tem1s of changes
due to havin g breast cancer and enduring breast cancer treatment, in order to avoid
confounding effec ts of changes related to other illnesses , seasonal changes in activities,
or life events.

It has been demonstrated that the SIP has high test-retest reliability (.92) and
internal consistency (.94). Additiona lly, validity has been demonstrated through
correlations wit h se lf-reported dysfunction (.69) and illness (.63 ; Bergner, Bobbitt ,
Carter, & Gilson, 1981 ). Prior to rescoring, reliability coeffic ient alphas for subsca les
used in the present stud y were .72 for home management, .73 for mobility , .70 for
recreation and pastimes, and .42 for work. The work subscale does not acco unt for
individ uals who arc not working because of nonhealth-related factors , like being retired
or unemplo yed (from a lay off) , and, therefo re, does not provid e an accurate assessment
of impairment in this area (Pollard & Johnston, 200 l ). Furthermore , due to the low
reliability of the work subscale, it was excluded from analyses .
Research ers have reported problems with the original method used to score the
SIP (McDowell & N ewe II, 1987; Pollard & Johnston, 2001; Post, de Bruin, de Witte, &
Schrijvers , 1996). The original scoring procedure produced an individual score for each
subscale or area of functioning , as well as a total score representative of general
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functioning. Each item in the various subscales was weighted to re flect the degree of
dysfunction that item represented. In order to obtain a percentage limitation score for a
particular subscale, the weighted score for each item endorsed was summed , divided by
· the maximum possible score for that subscale, and then multiplied by I 00. The problem
with this scoring procedure is related to the summin g of endorsed weighted items. An
individual who is functionally more impair ed than another , may appear to exhibit less
dysfunction due to endorsing fewer items. For example , if someone endorsed, "I am not
doing any of my usual physical recreation activities," it would imply that they would
logically not endorse other items within that subscal e such as, "I do my hobbi es and
recreation for shorter periods of time." Howeve r, using the original scoring procedure,
the more items the respondent endorses the higher the limit ation score. Therefore, i r
someone were to endorse the item representative of the highest limitation (e.g., I am not
doin g any of my usual physical recreation or activiti es), it would prec lude them from
endor sing other items and result in receiving a misleading score re flective of a lower
level of limitation than they actually experience. Pollard and Jolmston proposed a new
scoring method that produce s a limitation score that more accuratel y reflects the
individual ' s true level of functioning. They proposed using the item endorsed by the
respondent with the maximum weight. For example , if a respondent endorsed three
items, the item with the highest weight would be used to calculate the percent limitation
score.-The percent limitation score is then calculated by dividing the maximum item
weighting endorsed by the maximum item weighting in that subscale and multiplying
by 100 (see Figure 2). After rescoring , similar reliability coefficient alphas for the three
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max item weighting endorsed
100 •
max item weighting in subscale

Figure 2. Percent limitation score graph depicts the percent limitation score formula for
subscale scoring on the SIP.

subscales were obtained with .74 for home management , .7 1 for mobility , and .68 for
recreation and pastimes.

Impact of Events Scale-Revised (!ES)
The IES consists of 15-items that are answered on a 4-point Likert sca le (from
0 = not at ail, to 3 = often). ft was de signed to assess avoidant and intru s ive thoughts
and emotions (Horowit z, Wilner , & Alvare z, 1979) that are similar to avo idant and
intru sive symptoms characteristic of PTSD (Ame rican Psychiatric Association , 2000).
The JES is compr ised of two sub sca les that assess intru sive thoughts and fee ling s
(intrusive subscale) and avoidance of particular thoughts, feelings, and situations
(avoidance sub sca ie). Avoidance and intrusion sym ptoms are of particular int erest to the
current project, as research has demonstrat ed many breast cancer survivors exper ience
such distressirrg symptoms (Cordova et al., 1995). For purposes of this study,
participants were asked to complete the IES in relation to having breast cancer. The IES
determines the frequency participants have experienced a situation related to breast
cancer (i.e., "I tried not to talk about it," "Any reminder brought back feelings about it")
(Zilberg, Weiss, & Horowitz , 1982) and produces separate scores for the intrusion and
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avoidance subscales, as wel l as a total stress score. Clinical interpretation of total stress
sco res is as follows: 0-8, subclinica l range ; 9-25, mild range; 26-43, moderate range;

44-75, severe range (Marren & Christianson, 2004) . Furthermore, a score greater than
or equal to 20 on either subsca le is indicative of a high , clinical ly meaningful score
(Horow itz, 1982).
The IES has established test-retest reliability for the total assessment score (.87),
the intrusion subscale (.89), and the avoidance subscale (.79; Horowit z et al., 1979).
Reliabilit y coefficient alphas for the present project were .84 for the avo idance subscale,

.89 for the intrusion subscale, and .91 for th e complete measure .

Perception of Disclosur e (DJS)
The

ors was

a s ing le- item measure used to assess participants'

disclosure. Patiicipants'

history otpr ior

perception of the ex tent to which they had alrea dy expressed

their deepest thoughts and feelings about th e ir cancer exper ience throu gh w ritin g or
di sc us sion with others was assessed . Patiicipants rated the ex tent of prior di sc losure on
a sca le ranging from O (not at all) to 10 (complete disclosure).
This measure is sim ilar to those used in previous expressive writing research
(Greenberg & Stone, 1992; Pennebaker & Beall, 1986 ; Pennebaker et al., 1988).
However, research is mixed with regard to the impact of prior disclosure on one's
ability to benefit from an expressive writing intervention. For example, researchers
found that up to 75% of participants wrote about thoughts and feelings related to a
traumatic event that they had not previously disclosed to anyone. These particular
participants went on to experience a decrease in health problems (Pennebaker & Beall).
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G reenbe rg and Sto ne randomly ass igned par tic ipant s to either write about a pr ev iou s ly
discussed traumatic eve nt or a traumatic eve nt that th ey had " kept to th ems elves. " They
fo und no differences
undisclosed

in out co me between indi v idu a ls who wrote about a pr ev iousl y

traumatic event ve rsus those w ho wrote abo ut a traumatic eve nt th ey had

pr ev iously discussed w ith others . Further researc h is necessary to determine the impa ct
of prior disclosur e on the benefits one may exper ience as a res ult of exp ressive writing.

Linguistic Jnqw, T and Word Cou nt
(UIVC)
The LIWC was used to anal yze the lin g uistic content of express ive wr itin g
narratives. The LlWC was developed by Francis and Pennebaker
recently updated (Pennebaker

( 1993) and was

et al. , 2003). The UW C was deve loped to ana lyze

emotional , cogn iti ve, structural, and proce ss e lements of wr itt en and verba l speec h,
parti c ularly of individuals

who hav e exper ience d a traumatic or distressing

eve nt. T he

most recent vers io n of the L!WC co nta ins a defau lt dictionary made up of2,300

wo rds

and word stems. The d ictionary words are organ ize d int o wo rd ca tegories, including 17
sta nd ard lin g uistic dimensions
categories

(e.g ., word count, percentage

of pronouns,

numbers) , 25

related to ps yc ho logica l co nstru cts (e .g., PA, NA, cognition) , 19 categories

related to persona l co n cerns (e.g., wo rk, leis ur e act iv iti es), andlO catego ries pertaining
to re lat ivi ty (i.e., time, space, motion). Each word represents

applicable word

categories.

For example, the word "c ried" is contained in four different linguistic

categories,

including sadness, overall affect , negative emotion, and past tense verb. The

LIWC searches tex t files and calculates the percentage

of words in the text that reflect
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various linguistic dim ensions (e.g., soc ial processes, time, metaph ysica l issues, leisure
activity) as found in the comprehensive LIWC dictionary. The LIW C has adequate
validity demonstrated through positive correlations with independent jud ges' content
ratings (negative emotionality = .69; positive emotionality = .64).
The cunent project examined words reflecting positi ve emotion s (e.g., happy,
good, jo y), negativ e emotions (e.g., hate, worthless, scared), cognitive processes (e.g.,
know, because , consider), and verb tense (e.g. , walk, walked, will). The rationale for
examinin g these particular word categories is based on previous research. First, trauma
and disclosure theor ies indicate that the expression of one's thoughts and emotions
related to a distre ssing e\'c nt is necessary to process or make sense of the experie nce
(Nemeroff et al., 2006). Resea rch has demonstrated that individuals who were
instructed to express their deepest feelings about a distressing eve nt evidenced health
benefits, whereas those who merely wrote about the facts of an event did not (Esterling
ct al., 1990). Other researc hers found that individuals who wrote about the facts as well
as their feelings related to a traumatic eve nt evidenced significant improveme nts in
health problem s relative to individuals who just wrote about the facts of a trauma.
Furthermore , participants who wrote about facts and emotions experienced long-tem1
improvements in health , whereas those who just wrote about their emotions did not
(Pennebaker & Beall , 1986). Based on this research and the previously summarized
research on the resultant linguistic patterns of expressive writing interventions,
emotion-related words and cognitive process words were examined. Specifically , PA
and NA words were examined, as opposed to general affective processes , as this is the
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most comprehensive and descriptive way to examine emotional expression with the
LIWC. Lastly , researchers have found a relationship between the use of past tense verbs
and distress, indicating that the use of fewer past tense verbs is related to greater distress
(Pennebaker et al., 1997). Therefore , the cuITent project also examined verb tense.

Procedur e

Two weeks prior to radiation therap y completion, participants were recruited
during their routine medical appo intment. They were asked to comp lete a Participant
Screening Form in order to detem1ine whether they met inclusion criteria for the study.
One week prior to complet ion of treatment , participants who met inclusion criteria were
interviewed to obtain baseline data (demograp hic var iables, TES, S[P, PANAS. DIS).
Participants were then randomized to one of the three treatment group s. At participants'
final radiation therapy appointments , they were provid ed with instructions for
participating in the study. Pa1iicipants in the EW intervention were instructed to write
about their "ve ry deepest thoughts and feelings about [their] cancer and cancer
treatment. " They were asked to write for 30 minut es on 3 consecutive days over a 5-day
time period. Participants in the GHI control group were provided with general
infom1ation about where to find resourc es related to cancer and cancer treatment. The
JES, SIP, PANAS, and DIS were again completed by participants at 1 week, 4 weeks, 6
months, and 1 year postradiation treatment. This follow-up interval was chosen in order
ascertain both short-tenn and long-te1m effects of the intervention.
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CHAPTER IV
RESULTS

This section provides results of data analyses organized by research questions
presented in Chapter II. Preliminary analyses were first conducted to obtain descriptive
information (e.g., age, ethnicity, education, marital status, stage of disease, history of
prior treatment) for the participants. The preliminary analyses are followed by results of
statistical calculations guided by the research questions.
Analyses were conducted on an intent-to-treat basis. The principle of intentionto-treat as applied to statistical analyses and in relation to the current project, refers to
the practice of including all participants in all analyses regardless of whether they were
compliant with the treatment they were randomized to receive (e.g., as in clinical trials;
May, DeMets, Friedman, Furberg, & Passamani, 1981). Research has demonstrated
that, by excluding participants who did not adhere to the treatment protocol, results can
be easily biased. Treatment compliance is reasoned to be in and of itself a measure of
outcome. Therefore, if analyses are adjusted for treatment compliance (i.e., excluding
participants who were not compliant with the intervention), it results in one outcome
being adjusted for another outcome that may lead to confounding results (DeMets,
2004), inaccuracies, and difficulty in interpreting findings (Friedman , Furberg, &
DeMets, 1996). Therefore, all data collected from participants within the current project
were examined irrespective of treatment compliance in order to preserve internal
validity and avoid biasing treatment comparisons (Schulz & Grimes, 2002).
The intention-to-treat principle presented as an issue within the current project
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when it was discovered that all of the expressive writing group participants did not write
as instructed. Specifically, of the 89 participants who were randomized to the expressive
writing intervention, 67 wrote three times as instructed, two wrote two times, and two
wrote only one time. Eighteen people who were randomized to the treatment group did
not write at all. Reasons for not writing included overtly refusing to write, merely not
completing any of the writing sessions, leaving radiation treatment early (prior to the
patient's last radiation appointment when the treatment protocol was dispensed), and
unknown reasons. Other participants who did not write indicated that they had mailed
their expressive writing narratives; however, the researchers never received them (Table

3).

Preliminary Analyses

Prior to addressing the research questions for the present study, descriptive
analyses were conducted on baseline measures of age, ethnicity, marital status,

Table 3

Reasons for Not Writing
Frequency
(N = 18)
Reason

n

%

Refused

3

17

Did not comp lete

6

33

Left radiation treatment early

6

No information

4

22

Lost in the mail

4

22
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education, employment, religion, stage of disease, and history of prior psychiatric
treatment. The questionnaire utilized provided a list of five to eight specific options to
check for each demographic question. Therefore, in order to better summarize the
information provided, the data were collapsed to form conceptually meaningful groups
for marital status, education, and employment (Table 4).
Data were further analyzed for significant demographic differences between the
expressive writing treatment group and the general health information control group
utilizing t tests and chi-squared analyses. No statistically significant differences
between groups were found (Table 5). In addition, data were analyzed for differences

Table 4

Summary of Collapsed Demographic Groups
Category
Marital stan1s

Education

Participant response options

Collapsed groups

Single (never manied)
Separated or Divorced
Widow
Married
Cohabitating

1. Single:

never manied
separated
divorced

2. Manied :

married
cohabitating

gt" grade or less

1. Less than high school graduate:

Some high school
High school graduate /GED
Technical school graduate
Some college
Master's degree
Doctorate degree

2. High school graduate , some
college, and technical school
graduate
3. College graduate and above:

Employment
status

Full-time ( ~30 hours/week)
Part-time
Homemaker
Unemp loyed
Retired
Disabled

1

8 " grade or less
some high school

full-time
part-time
2. Unemployed: unemp loyed
homemaker
retired
disabled
1. Employed:

college graduate
master's degree
doctorate degree
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Table 5

Test of Statistical Differences Between Treatment and Control
Chi Square /!
Variable

value

p-value

value

Ethnicity

7.67

0.18

0.21

Marital status

0.82

0.37

0.07

Education

1.67

0.43

0. 10

Employment status

2.01

0.16

0.11

Religiosity

8.81

0.12

0.22

Breast cancer stage

0.10

0.95

0.02

Therapy since CA diagnosis

0.37

0.55

0.05

Focus of therapy

0.01

0.93

0.01

-0.56

0.57

0.09"

0.05

0.96

0.01 a

Age
Number of therapy sess ions
3

Cramer's V/SMDa

SMD

=

standardized mean difference as related tot test.

across demographic variables and baseline outcome variables for participants from the
data collection site in California versus those from the data collection site in Utah. No
significant differences were found with the exception of history of therapy since one's
cancer diagnosis (t = 3.00; p = 0.00). Specifically, of the 45 participants who reported
seeing a therapist since their breast cancer diagnosis, 20 were from the site in
California. This is noteworthy as 40.8% (N = 20) of participants from California had
previously seen a therapist, whereas only 19.2% of participants from Utah had seen a
therapist.
The final sample for the present study consisted of 180 participants (expressive
writing group= 89; general health information group= 91). Participant characteristics
are presented in Table 6. The majority were Caucasian (N= 145; 80.6%) and were
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Table 6

Summary of Participant Characteristics
Control group
(N = 91)

Treatment group
(N = 89)
11

%

n

%

21-34

2

2.0

8

8.1

35-44

16

17.7

11

12.2

45-54

26

29.0

31

34.1

Variable
Age

55-64

20

22.4

21

23.1

65 and Above

25

28.7

20

22.0

78

87.6

67

73.6

Hispanic

6

6.7

12

13.2

Asian

3

3.4

5

5.5

African American

0

0

1

1.1

Native American

0

0

3

3.3

Other

0

0

Ethnicity
Caucasian

1.1

Marita l Status
Single

26

29.2

32

35.2

M arried/coha bi ta ting

63

70.8

58

63.7

7

7.9

4

4.4

HS grad, some co llege,
Tech school

53

59.6

61

67.0

College grad and above

29

32.6

25

27.5

Emp loyed

41

46.1

52

57. 1

Unemp loyed

46

51.7

38

41.8

LDS

33

37. 1

33

36.3

Protestant

32

36.0

19

20.9

Catholic

12

13.5

22

24.2

Jewish

0

0.0

2

2.2

Other

3

3.4

5

5.5

9

10.1

8

8.8

Education
Less than HS grad

Emp loyment status

Religiosity
Religious

Not religious

(table continues)
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Treatment group
(N= 89)

Control group
(N = 91)

n

%

n

%

Stage I

37

41.6

37

40.7

Stage II

43

48.3

45

49.5

9

10.1

9

9.9

0-3 (little)

17

19.1

13

14.4

4-7 (moderate)

24

26.9

29

32 .3

8-10 (high)

48

54.0

48

53.3

Variable
Breast cancer stage

Stage III
Prior disclosure

Note. Percentages based on the number of participants who responded to
each individual question . The number of respondents for each question
ranged from 87 to 89 for the treatment group and from 89 to 90 for the
control group.

diagnosed with either stage I (N = 74; 41.1 %) or stage II (N = 88; 48.9%) breast cancer.
Participants ranged in age from 24 to 89 (mean= 54.81; SD= 12.64) . Many participants
were man-ied or cohabitating (N = 121; 67.2%) and noted affiliation with a particular
religion (N = 178; 89.5%). Approximately half of participants were employed (N = 93;
51.6%). Few participants noted seeing a therapist since their breast cancer diagnosis
(N = 45; 25%; see Table 7). The vast majority of those who had participated in therapy,

did so for fewer than five sessions (N = 37; 82.2%) and most utilized therapy to focus
on their cancer experience (N= 34; 75.6%). Furthermore, the majority of participants
(N = 96; 53.6%) indicated having engaged in a high degree of disclosure related to their

breast cancer experience prior to entering the study, while few reported having
disclosed relatively little (N = 30; 16.8%).
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Table 7
Therapeutic History
Treatment group
(N= 89)

Control group
(N = 91)

%

n

%

n

Therapy since CA diagnosis
Yes
No

24
64

27.0
71.9

21
69

23 .1
75.8

Focus of therapy
Cancer related
Other issues

18
6

75.0
25.0

16
5

76.2
23.8

Number of therapy sessions
1 session
2-5 sess ions
;;;:6sess ions

11
10
3

45 .8
41.7
12.5

9
7
3

42.9
33.3
14.3

Variable

Research Questions

Eff ect of Treatment

The first research question sought to determine whether an expressive writing
intervention had an impact on outcomes (PANAS: PA and NA; SIP: general
functioning; RIES : intrusion and avoidance symptoms), by specifically examining
changes in the EW treatment group outcome scores from baseline to each follow-up
point (1 week, 4 weeks, 6 months, 1 year) as compared to the GHI group scores. It was
originally proposed to answer this research question by conducting mixed factorial
ANOV As with one between subjects factor (treatment vs. control) and one within
subjects factor (time interval). However, after further exploration, it was determined
that linear mixed models would provide more accurate analyses of the data. This
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decision was based on three main factors. First, linear mixed models accommodate for
missing data, which is common when data is collected longitudinally (Fitzmaurice,
Lairds, & Ware, 2004), as in the present study. The current study contains missing data
for several reasons, including participants refusing to participate or to complete a
measure, incomplete measures, and losing measures in the mailing process. Linear
mixed models are able to accommodate for missing data by simultaneously modeling
for fixed effects (mean response or population characteristics shared by all participants)
and random effects ( effects unique to each individual participant; Fitzmaurice et al.). By
allowing for random variation across individuals, and thus multiple missing data points,
each individual's data are retained (Edwards, 2000). This not only provides a more
accurate picture of outcome, but also serves to maintain the integrity of the sample size,
which can impact power and statistical significance (Cohen, 1988) . Mixed factorial
ANOY As on the other hand, cannot accommodate for missing data, and in fact omit
participants if they have missing data. This can lead to sampling bias , as the analyses
are conducted solely on participants without missing data (Gueorguiva & Krystal,
2004) . Second, linear mixed models assume data to be dynamic; that is, longitudinal
data need not change in a linear pattern over time. Outcome data are not assumed to
change linearly, as in ANOV As, but are allowed to change in a nonlinear or curvilinear
manner. Lastly, it is common for an individual's outcome data to be correlated at each
follow-up point in a longitudinal design. In fact, the present study yielded correlations,
ranging from .20 (p = 0.02) to .76 (p = 0.00), between data points for the three outcome
measures (PANAS, SIP, IES). If correlations between individuals' repeated outcome
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scores are not considered, parameter estimations can be deflated, hypothesis tests are
likely to have increased Type I error, and statistical power may be decreased. To avoid
such bias, linear mixed models utilize the correlations or covariance between repeated
individual observations when modeling data (Edwards). Conversely, mixed factorial
ANOV As assume that the values of outcome observations are independent, which can
lead to such biases (Edwards) and nonnormality (Ferrell, 2005).
Prior to fitting the linear mixed models, general exploratory analyses were
conducted examining the relationship between group (EW and GHI) and outcomes
(PANAS, SIP, IES). Then, the relationship between each covariate of interest and
outcome was examined. The covariates of interest were age, breast cancer stage,
previous therapy, marital status, education , and prior disclosure. The decision to include
these particular covariates within the models was based upon findings of previous
research, results of exploratory analyses, and the nature of the intervention. Previous
research has indicated that younger individuals with breast cancer (typically under age
55) tend to respond to their cancer diagnosis with greater distress (Palmer et al., 2004),
increased symptoms of depression and anxiety (Kissane et al., 2004; Pinder et al., 1994;
Tibbs, 2003), and increased intrusion symptoms as compared to older individuals
(Tjemsland et al., 1996a , 1996b). Concerning cancer stage, more advanced stage cancer
is associated with increased incidence of PTSD (Jacobsen et al., 1998) and lower PA
(Voogt et al., 2005). Being married has also been associated with intrusive
symptomatology (Tjemsland et al., 1996a, l 996b ). In addition, it is hypothesized that a
history of participating in therapy (i.e., opportunity to express thoughts and emotions)
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may be related to outcome given that these individuals may have already had not be
assumed that just because one participated in therapy that she necessarily engaged in
meaningful disclosure. It also cannot be assumed that if one did not participate in
therapy, she has not disclosed her thoughts and feelings . Therefore, a measure of
perception of prior disclosure was also included as a covariate. Furthermore, provided
that the intervention in the present study involved expressing oneself through the act of
writing, it was hypothesized that education level may impact outcome . Lastly, results of
exploratory analyses revealed significant relationships between the aforementioned
covariates and various outcomes.
The structure of final models included one independent variable (intervention),
one dependent variable (outcome), and seven covariates (time, age, stage , previous
therapy, marital status, education, prior disclosure). Fixed effects (between-subjects
factor) within each model included group means for EW and GHI, and random effects
(within-subjects factor) included individual participant variables and the intercept. A
residual term was also included in the models, which allowed for random intercepts,
controlling for potential baseline differences. Interaction effects were originally
included in all final modeling. However, no significant interactions between group and
time were found for any model. In order to free up variance potentially accounted for by
the interaction terms, the interaction terms were removed from the models and the
models were rerun. In addition, due to the relatively few prior studies conducted on the
effects of expressive writing on breast cancer patients, and thus the exploratory nature
of the present study, hypotheses regarding which covariates would be most important to
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examine were not possible. Therefore, the final models presented are full models, which
retain all covariates irrespective of statistical significance.
PANAS Exploratory analyses were first conducted on PA (Figure 3). Both the

EW and GHI groups evidenced an increase in PA from baseline (EW: mean= 34.02,
SD= 7.30; GHI: mean= 33.11, SD= 7.80) to the 1-year follow-up (EW: mean= 38.09,
SD= 8.84; GHI: mean= 34.75, SD= 9.43). However, the EW group appears to have

made larger gains in PA at 1 year postradiation treatment as compared to the GHI group
(Table 8). Interestingly, the EW group's PA scores did not steadily increase from
baseline, but increased at 1 week by .90 of a point, decreased at 4 weeks by .69 of a
point, and then increased from that point forward. The GHI group had a slightly
different trajectory , with a decrease in PA at 1 week by 1.81 points and then increased
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Figure 3. PANAS: Mean PA scores. Graph depicts overall mean PA scores for
treatment versus control groups from baseline through 1 year posttreatment.
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Table 8
PANAS: Mean PA Outcome Scores for EWand GHI Groups
Time
1 week

Baseline

4 weeks

6 months

1 year

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

EW

34.02

7.30

34 .92

7.62

34.23

8.04

36.26

7.61

38.09

8.84

GHI

33.1 1

7.80

31.30

8.65

32.23

8.43

32.85

8.75

34.75

9.43

Variable
PANAS: PA

from that point forward. Furthermore, baseline PA scores for both groups were similar
to scores of individuals in the general population (33.3), when asked about their affect
over the past few days (Watson et al., 1988b) as in the present study.
With regard to the relationship between PA and the covariates, Pearson R
correlations revealed few significant relationships (Table 9). Specifically, a small
negative relationship was found between PA and cancer stage at baseline (r = -.20,
p

= 0.01), indicating that higher PA is associated with lower cancer stage. PA was also

positively associated with previous therapy at 4 weeks (r = .15, p

=

0.05) and education

at 6 months (r = .18, p = 0.02).
After exploratory analyses were performed a linear mixed model was fitted with
the seven predictor variables of time, age, stage, previous therapy, marital status ,
education, and prior disclosure , and one dependent variable of PA. Fixed effects
(between-subjects factor) within the model included PA group means for EW and GHI.
Random effects (within -subj ects factor) included individual participant variables and
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Table 9

Correlations Between PA Scores and Covariates
Previous
therapy

Marital
status

Prior
disclosure

Age

Cancer
stage

Baseline

.09 (0.29)

-.20 (0.01 )*

.12(0 .11)

-.04 (0.61)

.07 (0.35)

.18 (0.02)*

1 week

.03 (0.73)

-.13 (0.10)

.06 (0.45)

.04 (0.59)

.09 (0.26)

.19 (0.01)*

4 weeks

.03 (0.72)

-.09 (0.24)

.15 (0.05)*

-.03 (0.66)

.01 (0.92)

.17 (0.02)*

6 months

-.07 (0.40)

-.14 (0.08)

.06 (0.44)

.15 (0.06)

.18 (0.02)*

.17 (0.03)*

I year

.07 (0.44)

-.IO (0.27)

.01 (0.88)

.09(0.31)

.12 (0.17)

.08 (0.32)

Outcome

Education

PANAS: PA

* p-value :-=;0.05.

the intercept. A residual term was also included in the model, which allowed for random
intercepts. As shown in Table 10, results yielded a significant intervention effect for
PA . This indicated that the EW group evidenced a significantly larger increase in PA
over time as compared to the GHI group, but the GHI group significantly improved
over time as well. Cancer stage was demonstrated to have a significant impact on
outcome , such that individuals with a more advanced stage breast cancer tended to have
lower PA. Please note that participants within the study had stage I, II, or III breast
cancer. Therefore, "more advanced stage cancer" is in reference to participants of this
study, as opposed to individuals with stage IV (advanced stage) cancer. Previous
disclosure was also significantly related to PA, indicating the greater degree of prior
disclosure the higher the reported PA.
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Table 10

Linear Mixed Model: PA
95% Confidence
interval
Regression
coefficient

SE

28.30

4.31

Intervention

2.57

Time

p-value

Lower

Upper

6.58

0.00*

19.8 1

36.80

0.94

2.72

0.01 *

0.71

4.43

0.04

0.01

3.04

0.00*

0.01

0.07

Age

-0.02

0.04

-0.41

0.69

-0.09

0.06

Cancer stage

-1.63

0.76

-2.15

0.03*

-3.13

-0.13

2.10

1.15

1.82

0.07

-0.17

4.36

-0.11

1.01

-0.11

0.91

-2.10

1.88

Education

0.91

0.88

1.03

0.30

-0.83

2.64

Prior disclosure

0.46

0.16

2.92

0.00*

0.15

0.77

Variable
Intercept

Therapy
Marital status

* p-va lue ::::;0.05.p

Variance and covariance estimates for the random parameters of the model were
also examined and are presented in Table 11. Analyses revealed that the intercept varied
significantly across individuals (UN; 1,1), but there was not an interaction between the
intercept and linear slope across participants (UN; 2,1). However, the linear slope
varied significantly across individuals (UN; 2,2).
Exploratory analyses on the trajectory of NA across the year of follow-up
indicated a slow decline in scores (Figure 4). Although the treatment group evidenced a
mean NA score that was 1.71 points lower than the GHI group at baseline, this
difference was not found to be statistically significant (t = 1.55, p = 0.12). From
baseline to 1 week (first postintervention assessment) NA scores decreased by 1.41
points for the EW treatment group and by 1.85 points for the GHI group (Table 12).
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Table 11

Estimates of Covariance Parameters: PA
95% Confidence
interval
Estimat e

SE

WaldZ

p-value

Lower

Upper

Residual

27.56

1.79

15.40

0.00*

24.26

31.29

UN (1, 1)

32.63

4.64

7.04

0.00*

24 .69

43 .11

UN (2, 1)

-0.06

0.09

-0.64

0.52

-0.25

0.12

UN (2,2)

0.01

0.00

3.48

0.00*

0 .01

0.02

Parameter

* p-value

~

0.05 .
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Figure 4. PANAS: Mean NA scores. Graph depicts overall mean NA scores for
treatment versus control groups from baseline through 1-year posttreatment.

79
Table 12

PANAS: Mean NA Outcome Scores for EW and GHI Groups
Time
Baseline

1 week

4 weeks

6 months

1 year

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

EW

17.81

6.95

16.41

6.84

16.48

6.75

16.77

7.54

14.31

5.36

GHI

19.52

7.78

17.67

7.48

17 .11

7.50

16.72

6.82

16.0 1

5.93

Variable
PANAS:NA

Scores for the EW and GHI groups then diverged in their trajectories. The EW
treatment group evidenced a slight increase in NA from 1 week to 6 months and then a
sharp decrease from 6 months to 1 year. Conversely, the GHI group evidenced a slight
but steady decline in scores from 1 week to the 1 year follow-up assessment.
Furthermore, baseline NA scores for both groups were similar to scores of individuals
in the general population (17.4), when asked about their affect over the past few days
(Watson et al., 1988b) as in the present study.
Preliminary analyses of the relationship between NA scores and covariates
revealed few and inconsistent relationships (Table 13). Specifically, age was associated
with NA at baseline and 1 week, suggesting that younger individuals experienced
greater NA. Breast cancer stage was found to have a positive relationship with NA at
baseline and 1-week postradiation treatment, indicating that as breast cancer stage goes
up, NA scores also tend to increase. Furthermore , previous therapy was negatively
related to NA at baseline (but at no other time point), suggesting that participants who
had higher levels of NA did not have a history of previous therapy. Marital status was
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Table 13

Correlations Between Baseline NA Scores and Covariates

Age

Cancer
stage

Previous
therapy

Baseline

-.21 (0.01)*

.18 (0.02)*

1 week

-.17 (0.03)*

4 weeks

Prior
disclosure

Marital
status

Education

-.17 (0.02)*

.04 (0.64)

-.03 (0.74)

-.13 (0.08)

.25 (0.00)*

-.11(0.18)

.02 (0.80)

-.08 (0.32)

-.05 (0.56)

-.10 (0.21)

.09 (0.22)

-.04 (0.62)

-.07 (0.37)

-.00 (0.95)

-.06 (0.46)

6 months

-.07 (0.37)

.11 (0.15)

-.04 (0.66)

-.07 (0.40)

-.04 (0.65)

-.07 (0.35)

1 year

-.12 (0. 15)

.15 (0.10)

-.03 (0.71)

-.25 (0.00)*

-.14(0 .10)

-.12 (0.18)

Outcome
PANAS : NA

* p-value ::::::
0.05.

also related to NA, indicating that participants who were single tended to experience
increased NA at I-year posttreatment.
After exploratory analyses were perfo1med, a linear mixed model was fitted with
identical predictor and dependent variables used for the PA model. Results revealed no
significant intervention effect (Table 14). However , all participants evidenced
significant improvements in NA over time. Furthermore, more advanced breast cancer
was associated with higher levels of NA.
JES. Exploratory analyses were conducted on intrusion and avoidance symptoms

(IES) . With regard to intrusion symptoms , general trends indicated a slight decrease in
symptoms from baseline through the 4-week follow-up period (Figure 5). Then, the EW
group evidenced an increase in intrusion symptoms at 6 months (M= 10.52; SD = 9.15)
and a sharp decrease at 1 year (M

=

7.53; SD= 7.24). Conversely, the GHI group

reported a slight decrease in symptoms from baseline to the 6-month follow-up, with a
sharper decline at I-year postradiation treatment (Table 15). With regard to participant's
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Table 14

Linear Mixed Model: NA
95% Confidence
interval
Regression
coefficient

SE

Intercept

23.82

3.76

Intervention

-0 .79

Time
Age

Variable

p-value

Lower

Upper

6.33

0.00*

16.39

31 .25

0.82

-0.96

0.34

-2.41

0.83

-0.03

0.01

-3 . 18

0.00*

-0.05

-0.01

-0 .06

0.03

-1.67

0.10

-0.12

0.01

1.55

0.67

2.33

0.02*

0.24

2.86

Therapy

-0.55

I.OJ

-0 .55

0 .58

-2 .55

1.44

Marital status

-1.03

0.88

-1.17

0.24

-2.76

0.70

Education

-0 .87

0.77

-1.13

0.26

-2.38

0 .65

Prior disclosure

-0.16

0.14

-1.15

0.25

-0.43

0.11

Cancer stage

* p-valu e

~

0.05.
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Figure 5. IES: Mean intrusion scores. Graph depicts overall mean intrusion scores for
treatment versus control groups from baseline through 1-year posttreatment.
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Table 15

!ES: Mean Intrusion Outcome Scores for EW and GHI Groups
Time
Baseline

1 week

Mean

SD

Mean

SD

EW

10.76

8.80

10.57

8.36

GHI

10.27

9.47

9.69

8.71

Variable

6 months

4 weeks

1 year

SD

SD

Mean

SD

9.71

8.54

10.52

9.15

7.53

7.24

9.26

9.14

9.07

8.67

7.39

6.88

Mean

Mean

IES: Intrusion

average total stress scores (sum of intrusion and avoidance scores), both the EW and
GHI groups reported symptoms in the mild range from baseline (M

=

21.69;

SD= 16.90) through 1 year (M= 15.36; SD= 14.31) postradiation treatment.
Research has indicated that obtaining a score

~

20, on either the intrusion or

avoidance subscale, is indicative of significant stress that necessitates further
assessment and potential intervention (Horowitz, 1982). Therefore, intrusion scores
were examined with regard to the frequency with which the clinical cutoff score ( ~ 20)
was obtained (Table 16). Due to having similar scores, this was examined for both the
EW and GHI groups combined. Approximately 14% of individuals obtained a high
score (at or above 20) on the intrusion subscale from baseline through the 4-week
follow-up point. Scores at 1-year postradiation treatment indicated an almost 50%
decrease in the number of participants scoring at or above this clinical cutoff.
Exploratory analyses were also conducted on the relationship between intrusion
symptoms and covariates (Table 17). The most consistent significant relationships were
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Table 16

Intrusion Subscale: Frequency of Scoring 2::20 (clinical cutojj)
Time
1 week

Baseline
N

IES
Intrusion

%
14.J

12

N
12

4 weeks

%
14.1

N
12

1 year

6 months

%

N

14.1

13

%
16.0

N
6

%

8.2

Note . Percentages are based on the number of individuals who responded to the IES questionnaire at
each time point.

Table 17

Correlations Between Intrusion Scores and Covariates

Outcome

Age

Cancer
stage

Previous
therapy

Marital
status

Education

Prior
disclosure

IES: Intrusion
Baseline

-.21 (0.01)*

. 13 (0.09)

-. 13 (0.09)

.04 (0.61)

.07 (0.37)

-.10 (0.17)

I week

-.29 (0.00)*

.21 (0.01)*

-. 15 (0.05)*

.04 (0.60)

.0 I (0.96)

-.07 (0.40)

4 weeks

-.29 (0.00)*

. 16 (0.03)*

-.11 (0.16)

-.03 (0.68)

-.00 (0.99)

-.04 (0.60)

6 months

-.28 (0.00)*

.16 (0.05)*

-.07 (0.41)

-.04 (0.61)

.05 (0.50)

-.08 (0.33)

I year

-.33 (0.00)*

.08 (0.34)

-.08 (0.34)

-.05 (0.54)

.05 (0.58)

-.10 (0.25)

* p-value

~

0.05.

found between intrusion symptoms and age (significant at all time points except 1 week
postradiation treatment) and intrusion symptoms and cancer stage (significant at 1
week, 4 weeks, and 6 months). These findings indicated that younger individuals tend to
experience more intrusion symptoms than their older counterparts and individuals with
more advanced cancer also experienced more intrusion symptoms than individuals with
less advanced breast cancer. In addition, previous therapy was found to be related to
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intrusion symptoms at I-week postradiation treatment, indicating that individuals with
no history of previous therapy experienced greater intrusion symptoms.
After exploratory analyses were performed, a linear mixed model was fitted with
the seven predictor variables of time, age, stage, previous therapy, marital status,
education, and prior disclosure, and one dependent variable of intrusion. Fixed effects
(between-subjects factor) within the model included intrusion group means for EW and
GHI. Random effects (within-subjects factor) included individual participant variables
and the intercept. A residual term was also included in the model, which allowed for
random intercepts , controlling for potential baseline differences. As shown in Table 18,
results indicated no intervention effect (regression coefficient= 0.81; p = 0.42). A
significant time effect was found (regression coefficient = -0.03; p = 0.00) indicating
participants tended to experience a decrease in intrusion symptoms over time. Lastly ,
there was a significant relationship between age and intrusion symptoms (regression
coefficient = -0.18 ; p = 0.00) with younger individuals experiencing higher levels of
intrusive symptoms as compared to their older peers .
With regard to avoidance symptoms , the EW and GHI groups evidenced similar
trajectories over time (Figure 6). As seen in Table 19, participant's scores remained
relatively constant from baseline to 6 months posttreatment (ranging from a mean of
11.20 to 10.84). Reported avoidance symptoms then sharply decreased from 6 months
to 1 year for both the EW and GHI groups (EW: M= 7.94, SD= 8.61; GHI: M = 7.75,
SD= 9.29).
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Table 18

Linear Mixed Model: Intrusion Symptoms
95% Confidence
Interval
Variable
Intercept

Regression
coefficient

SE

,e-value

Lower

u~~er

19.53

4 .73

4 .13

0.00*

10.20

28.86

0.84

1.03

0.82

0.42

-1.20

2.88

Time

-0.03

0.01

-3.04

0.00*

-0.06

-0 .01

Age

-0.18

0.04

-4.23

0.00*

-0.27

-0.10

1.49

0.84

1.78

0.08

-0.16

3.14

Therapy

-0.44

1.27

-0.35

0.73

-2.95

2.06

Marital Status

-0.58

1.10

-0.52

0.60

-2.76

1.60

0.50

0.96

0.52

0.60

-1.40

2.40

-0.18

0.17

-1.06

0.29

-0.52

0.16

Intervention

Cancer Stage

Education
Prior Disclosure
~

* p-value

0.05.
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Figure 6. IES: Mean avoidance scores. Graph depicts overall mean avoidance scores for
treatment versus control groups from baseline through I-year posttreatment.
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Table 19
JES: Mean Avoidance Outcome Scores for EW and GHI Groups
Time
Baseline

1 week

4 weeks

1 year

6 months

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

EW

11.10

9.68

10.77

9.64

11.45

9.60

10.37

10.06

7.94

8.61

GHI

11.20

9.54

11.01

10.92

10.62

10.35

10.84

10.29

7.75

9.29

Variable

Mean

IES : Avoidance

Avoidance scores were also examined with regard to the frequency with which
participants scored at or above the clinical cutoff ( ~O). Approximately one fifth of
participants evidenced high scores from baseline to 6 months (Table 20), indicating the
experience of a significant stress response. Furthem1ore, similar to the trajectory for
intrusion scores , the number of participants who obtained a score within this clinical
cutoff decreased by about 50% at 1-year postradiation treatment.
Further exploratory analyses revealed few significant relationships between
avoidance symptoms and covariates (Table 21 ). Specifically , symptoms of avoidance
were related to age at the 4-week follow-up (r = -.07, p = 0.03) and to previous therapy
at baseline (r = -.17, p

=

0.02). The experience of avoidance symptoms was consistently

negatively related to a history of prior disclosure, indicating that a smaller degree of
prior disclosure was associated with the experience of more avoidance symptoms.
After exploratory analyses were performed, a linear mixed model was fitted with
identica l predictor and dependent variables used for the intrusion model (Table 22). The
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Table 20
Avoidance Subscale: Frequency of Scoring :2:20
Time
Baseline

1 week

4 weeks

6 months

1 year

TES

N

%

N

%

N

%

N

%

N

%

Avoidance

19

21.4

19

21.4

18

21.6

17

20.8

7

9.9

Note . Percentages are based on the number of individuals who responded to the IES questionnaire at
each time point.

Table 21
Corre lations Between Avoidance Scores and Covariates

Age

Cancer
stage

Previous
therapy

Marital
status

Education

Prior
disclosure

Baseline

-.04 (.062)

-.0 1 (0.90)

-.17 (0.02)*

.12(0.12)

-.07 (0.38)

-.21 (0 .00)*

I week

-.09 (0.27)

.07 (0.36)

~.13 (0.10)

.09 (0.24)

-.09 (0.25)

-.26 (0.00)*

4 weeks

-.17 (0.03)*

.05 (0.51)

-.10 (0.20)

.07 (0.38)

-.08 (0.28)

-.22 (0.00)*

6 months

-. 14 (0.08)

.07 (0.36)

-.03 (0.67)

-.05 (0.50)

-.03 (0 .73)

-.23 (0.00)*

I year

-.14 (0. 11)

.11 (0.18)

-.05 (0.55)

-.02 (0.83)

-.04 (0.68)

-.25 (0.00)*

Outcome
IES: Avoidance

* p-value

s 0.05.

model failed to reveal a significant treatment effect (Regression Coefficient = -0.13,
p = 0.91). However, all participants evidenced significant improvements in avoidance

symptoms over time (Regression Coefficient= -0.04, p = 0.00). History of prior
disclosure was also significantly related to avoidance symptoms (regression
coefficient= -0.77,p = 0.00).
SIP. Exploratory analyses on limitation in the area of home management

revealed a decline in limitation over time with a sharper decrease from 1 week to 1 year
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Table 22

Linear Mixed Model: Avoidance Symptoms
95% Confidence
interval
Regression
coefficient

SE

2-value

Lower

Ueeer

Intercept

23.71

5.589

4.25

0.00*

12.69

34.74

Intervention

-0.13

1.22

-0.11

0.91

-2.55

2.28

Time

-0.04

0.01

-3.45

0.00*

-0.06

-0.02

Age

-0.07

0.05

-1.34

0. 18

-0.17

0.03

0.31

0.99

0.3 1

0.76

-1.64

2.25

-2.43

1.49

-1.63

0.11

-5.38

0.51

1.45

1.31

1.11

0.27

-1 .14

4 .03

Education

-0.98

1.14

-0.86

0.39

-3.23

1.27

Prior disclosure

-0.77

0.21

-3.74

0.00*

-1.17

-0.36

Variable

Cancer stage
Therapy
Marital status

* p-value

~

0.05.

postradiation treatment (Figure 7). No significant differences were found between the
EW and GHI groups at baseline (t = 0.95, p = 0.34) and both groups shared a similar
change trajectory across time. As discussed previously, SIP scores are reported as a
percentage of limitation. Therefore, participants evidenced a decrease in limitation in
home management activities from being about 50% limited to a limitation of less than
25% (Table 23). That is, their limitation in this area of general functioning improved by
50% over the year following radiation treatment.
With regard to the relationship between limitation in home management
activities and specific covariates, analyses indicated several notable relationships (Table
24). Functioning in home management was significantly related to cancer stage in an
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Figure 7. SIP: Mean home management scores. Graph depicts overall mean Home
Management scores for treatment versus control groups from baseline through 1-year
posttreatment.

Table 23

SIP: Mean Home Management Outcome Scores for EWand GHI Groups
Time
Baseline
Variable

Mean

1 week

4 weeks

6 months

1 year

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

IES: Home mana geme nt
EW

47.65

34.16

46.96

36.58

40.01

37.79

34.74

37.87

22.62

33.75

GHI

52.22

30.19

48.33

36.28

41.25

34.84

33.95

36.79

24.89

34.20
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Table 24

Correlations Between Home Management Scores and Covariates

Outcome

Age

Cancer
stage

Previous
therapy

Marital
status

Education

Prior
disclosure

SIP: Home management
Baseline

-.02 (0. 76)

.21 (0.00)*

-.16 (0.03)*

.04 (0.58)

-.20(0.01 )*

-.03 (0.67)

I week

.03 (0.73)

.17 (0.03)*

-.01 (0.87)

-.04 (0.64)

-.20 (0.01)*

.03 (0. 70)

4 weeks

-.09 (0.26)

.20 (0.01)*

-.18 (0.02)*

-.23 (0.00)*

-.09 (0.24)

.03 (0.73)

6 months

.02 (0.80)

.16 (0.05)*

-.16 (0.04)*

-.14 (0.07)

-.06 (0.45)

-.02 (0.80)

I year

.13(0.13)

.07 (0.43)

-.15 (0.07)

-.11 (0.20)

-.04 (0.65)

.08 (0.33)

* p-value

~

0.05.

expected direction, with more advanced cancer related to increased limitation in this
area at baseline (r = .21, p 0.00) through the 6-month follow-up (r = .16, p = 0.05) .
Results indicated a small relationship between previous therapy and home management,
in that those with a history of previous therapy experienced less limitation as compared
to those with no psychotherapy history. This relationship was significant at baseline

(r = -.16, p = 0.03), 4 weeks (r = -.18, p = 0.02), and 6 months (r = -.16, p = 0.04). In
addition, education was negatively related to home management at baseline (r = -.20 ,

p = 0.01) and 1 week only (r = -.20,p = 0.01), meaning that those with lower levels of
education tended to evidence greater limitation in this area. Lastly, marital status was
negatively related to home management at 4 weeks (r = -.23, p = 0.00), indicating being
single at the time of the study was related to greater limitation in this area of functioning
as compared to being married or cohabitating.
After exploratory analyses were performed, a linear mixed model was fitted with
the seven predictor variables of time, age, stage, previous therapy, marital status,
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education, and prior disclosure and one dependent variable of home management. Fixed
effects (between-subjects factor) within the model included home management group
means for EW and GHI. Random effects (within-subjects factor) included individual
participant variables and the intercept. A residual tem1 was also included in the model,
which allowed for random intercepts. As shown in Table 25, no significant intervention
effect was found (regression coefficient= -1. 76, p = 0.62). However, participants
evidenced significant improvement in home management limitations across time
(regression coefficient= -0.39, p = 0.00). Furthermore, several covariates predicted this
change over time. Specifically, breast cancer stage (regression coefficient= 8.40,
p = 0.00), previous therapy (regression coefficient= -10.69,p = 0.02), and education

(regression coefficient= -8.85,p = 0.01) were significantly related to outcome.

Table 25
Lin ear Mixed Model: Hom e Management

p-value

95% Confidence
interval
-----Lower
Upper

4.17

0.00*

35.63

99.74

3.57

-0.49

0.62

-8.80

5.29

-0.39

0.54

-7.26

0.00*

-0.50

-0.29

Age

0.17

0.15

0.16

0.25

-0.12

0.46

Cancer stage

8.40

2.88

2.92

0.00*

2.72

14.09

-10.69

4.37

-2.45

0.02*

-19.30

-2.07

Marital status

-5.12

3.81

-1.35

0.18

-12.64

2.39

Education

-8.85

3.31

-2.67

0.01 *

-15.39

-2.31

0.35

0.60

0.59

0.56

-0.82

1.52

Regression
coefficient

SE

Intercept

67.68

16.24

Intervention

-1.76

Time

Variable

Therapy

Prior disclosure
* p-value ::;;0.05.
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Exploratory analyses related to the mobility subscale of the SIP revealed unique
changes over time (Figure 8). No significant differences were found between the EW
and GHI group at baseline (t = 0.77,p = 0.44). As seen in Table 26, at I-week
postradiation treatment both groups reported an increase in mobility limitations (EW:

M = 23.27, SD= 32.94; GHI: M = 30.92, SD= 35.93), with the GHI group experiencing
a greater increase in limitation. Both groups subsequently reported consistent decreases
in limitation at 4 weeks (EW: M= 21.28, SD= 33.36; GHI: l'vf= 18.27, SD= 29.67), 6
months (EW: M= 12.71, SD= 27.33; GHI: M= 13.29, SD= 28.73), and 1 year (EW:

M= 10.21, SD= 23.11; GHI: M= 9.75, SD= 25.31) . Overall, participants evidenced a
range of 12-16% improvement in functioning in the area of mobility across the year
follow-up.
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Figure 8. SIP: Mean mobility scores. Graph depicts overall mean Mobility scores for
treatment versus control groups from baseline through I-year posttreatment.
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Table 26
SIP: Mean Mobility Outcome Scores for EW and GHI Groups
Time
Baseline

l week

4 weeks

l year

6 months

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

EW

21.86

32 .31

23.27

32.94

21.28

33.36

12.71

27.33

10.21

23.11

GHI

25.69

33.75

30.92

35.39

18.87

29.67

13.29

28.73

9.75

25.31

Variable
SIP: Mobility

Exploratory analyses were then conducted with mobility and the covariates. A
consistent relationship was found between limitation in mobility and previous therapy
across all time points (Table 27), indicating that individuals with a history of
participating in psychotherapy tended to experience decreased limitation in this area.
Breast cancer stage was found to be positively related to mobility at baseline (r = .24,
p = 0.00), 1 week (r = .29, 0.00), and 4 weeks (r = .18, p = 0.02), denoting that

increased limitation is associated with more advanced breast cancer. Lastly , a
significant relationship was also found between marital status and mobility at the 6month follow-up (r = -.19, p = 0.02).
After exploratory analyses were performed, a linear mixed model was fitted with
identical predictor and dependent variables used for the home management model
(Table 28). Analyses indicted that the model found no significant intervention effect
(regression coefficient= -1.23, p = 0.69). However, participants evidenced a decrease in
mobility limitations over time (regression coefficient= -0.25, p = 0.00). Furthermore,
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Table 27
Correlations Between Mobility Scores and Covariates
Marital
status

Education

Prior
disclosure

-.17 (0.03)*

-.10 (0.21)

-.12 (0 .12)

.02 (0.81)

.29 (0.00)*

-.26 (0.00)*

.00 (0.96)

-.04 (0.64)

.09 (0.25)

-.07 (0 .34)

.18 (0.02)*

-.18 (0.02)*

.05 (0.55)

-.05 (0.48)

-.06 (0.43)

.06 (0.46)

.03 (0.71)

-.18 (0.02)*

-.19 (0.02)*

.03 (0.74)

.04 (0.64)

-.01 (0 .87)

.05 (0.59)

-.24 (0.01)*

-.01 (0.95)

.00 (0.96)

.02 (0.85)

Age

Cancer
stage

Previous
therapy

Baseline

-.12 (0.11)

.24 (0.00)*

I week

-.05 (0.52)

4 weeks
6 months

Outcome
SIP: Mobility

I year

s

* p-value

0.05.

Table 28
Linear Mixed Model: Mobility
95% Confidence
interval
Regression
coefficient

SE

Intercept

42 .20

13.93

Intervention

-1.23

Time

Variable

p-value

Lower

Upper

3.03

0.00*

14.68

69.73

3.06

-0.40

0.69

-7.28

4.81

-0.25

0.69

-5 .17

0.00*

-0.34

-0.15

Age

0.13

0.13

1.01

0.32

-0 .12

0.38

Cancer stage

4.60

2.50

1.84

0.07

-0.34

9.73

-13.65

3.78

-3.61

0.00*

-21.12

-6.18

Marital status

-2 .53

3.26

-0.78

0.44

-8.97

3.91

Education

-2.87

2.85

-1.01

0.32

-8.49

2.76

0.12

0.51

0.24

0.81

-0.88

1.13

Therapy

Previous disclosure
* p-value

s 0.05 .
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history of previous therapy was found to predict improvements over time (regression
coefficient= -13.65,p = 0.00).
Exploratory analyses for the recreation and pastimes subscale of the SIP
revealed that the EW and GHI groups were significantly different at baseline (t = 2.61,
p = 0.01). However, due to including random effects within the linear mixed model, this

baseline difference was controlled for, making interpretations of findings possible. With
regard to the trajectory of change across time (Figure 9), the EW group evidenced a
steady decrease in limitation in recreation and pastimes . The GHI group experienced an
increase in limitation in this area of functioning at I-week postradiation treatment , but
then sharply decreased in limitation through the one year follow-up (Table 29).
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Figure 9. SIP: Mean recreation and pastime scores. Graph depicts overall mean
recreation and pastimes scores for treatment versus control groups from baseline
through I-year posttreatment.
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Table 29

SIP: Mean Recr eation and Pastimes Outcome Scores for EW and GHI Groups
Time
Ba seline
Variable

Mean

1 week

4 weeks

6 months

1 year

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

SIP : Recreation and pastimes
EW

38.01

31.82

41.02

32.18

36 .64

33 . 19

31.89

32 .22

20 .99

29.56

GHI

49.83

28.20

42 .50

33 .51

35.90

34.29

28 .32

32.53

19.86

29 .33

Exploratory analyses were conducted to determine the relationship between
limitation in the area ofrecreation

and pastime and covariates (Table 30). A significant

relationship was found for cancer stage with greater limitation associated with more
adv anced stage breast cancer (1 week: r = .18, p = 0.02; 4 weeks: r = .25, p = 0.00; 6
months : r = .18, p = 0.03). A significant relationship was also found for previous
therap y at 4 weeks (r = -.18, p = 0.02) and 1 year (r = -.25 , p = 0.00) postinterv ention.
After exploratory analyses were performed, a linear mixed model was fitted with
the same seven predictor variables (time , age , stage, previous therapy, marital status,
education , prior disclosure) and one dependent variable (PA) as used in previous
models (Table 31). Fixed effects (between-subjects

factor) within the model included

recreation and pastimes group means for EW and GHI. Random effects (within-subjects
factor) included individual participant variables and the intercept. Particularly important
to this model, a residual term was included, which allowed for random intercepts and
controlled for the baseline difference. The model revealed no significant intervention
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Table 30

Correlations Between Recreation and Pastime Scores and Covariates

Outcome

Cancer
stage

Age

Previous
therapy

Marital
status

Education

Prior
disclosure

SIP: Recreation & Pastime
Baseline

-.10 (0 .24)

.14 (0.07)

-.11(0 . 16)

.03 (0.67)

-.05 (0.53)

.05 (0.51)

I week

-.13 (0.10)

.18 (0.02)*

-.11(0 .14)

-.05 (0 .50)

-.05 (0.53)

.01 (0.87)

4 weeks

-.08 (0.33)

.25 (0.00)*

-.18 (0.02)*

-.05 (0.50)

.02 (0 .84)

.03 (0.65)

6 months

-.04 (0.59)

.18 (0.02)*

-. 13 (0.10)

-.14 (0.07)

-.03 (0 .75)

.07 (0.40)

I year

-.08 (0.34)

.14(0.ll)

-.25 (0.00)*

-.02 (0.86)

-.08 (0.34)

.05 (0.53)

~

* p-value

0.05.

Table 31

Lin ear Mixed Model: Recreation and Pastime
95% Confidence
Interval
Regression
coefficient

SE

Intercept

53.93

15.80

3.41

Intervention

-1.36

3.47

Time

-0.38

Age

Variable

p-value

Lower

Upper

0.00*

22.74

85.12

-0.39

0.70

-8.21

5.50

0.05

-7.18

0.00*

-0.48

-0 .28

-0.05

0.14

-0.32

0.75

-0.33

0.24

7.78

2.81

2.77

0.01 *

2.23

13.34

Therapy

-8.66

4.26

-2.03

0.04*

-17.07

-0.25

Marital status

-2.69

3.70

-0.73

0.47

-10 .00

4.61

Education

-3.28

3.22

-1.02

0.31

-9.64

3.08

0.50

0.58

0.87

0.39

-0.64

1.64

Cancer stage

Previous disclosure
* p-va lue

~

0.05.
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effect (regression coefficient= -1.36, p = 0. 70). However, both groups of participants
significantly improved over time (regression coefficient= -0.38, p = 0.00). Furthermore,
breast cancer stage (regression coefficient= 7.78,p = 0.01) and previous therapy
(regression coefficient= -8.66, p = 0.04) significantly predicted outcome, in that more
advanced stage breast cancer predicted greater limitation and previous therapy predicted
decreases in limitation over time.
Summa ry. To summarize the findings for the first research question , the
expressive writing intervention evidenced a significant positive impact on reported PA .
No significant intervention effects were found for the other outcome measures .
However, both the EW and GHI groups demonstrated significant improvements in NA,
intrusion and avoidance symptoms, and limitations in home management, mobility , and
recreation and pastime over time.

Ling uistic Analyses
Prior to answ ering the second research question , descriptive analyses were
conducted on the expressive writing narratives. Utilizin g the LIWC program , the mean
percent of words utilized from particular linguistic categories was first determined (see
Tables 32 and 33) . Participants wrote an average of 473 words during each of the three
writing sessions (range= 19-1,644). The total word count of the narratives decreased
significantly from the first to the third writing session (writing 1 to writing 2: t = 4.68,
p = 0.00; writing 2 to writing 3: t = 2.93 , p = 0.01) .

With regard to affect when averaging across the three writing sessions, less than
5% of total words used were positive or negative emotion words (positive emotion:
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Table 32

Linguistic Analyses of Expressive Writing Narratives: Part I
Positive emotion
words

Total words

Negative emotion
words

Cog nitive words
Mean
%

range

0.33-4.73

7.56

3.20-11.77

2.01

0.00-6.72

7.40

1.60-12.77

0.00-13.23

1.94

0.00-10.53

7.36

3.30-13 .04

0.00-13.23

2.02

0.00-10.53

7.46

1.60- 13.04

Writing session

Mean
%

range

Mean
%

range

Mean
%

Writing I (N = 68)

566.55

119-1644

2.32

0.37-4 .91

2.09

Writing 2 (N = 65)

466.88

47-1314

2.90

0.00-8.49

Writing 3 (N = 66)

401.11

19-1461

3.22

Combined writings

473.02

71-1252

2.80

range

(N= 200)

Table 33

Linguistic Analyses of Expressive Writing Narratives: Part II
Tense
Past

Present

Future

Writing session

Mean%

range

Mean %

range

Mean%

range

Writing I (N = 68)

7 58

0.84-13.82

9.82

3.07-22.69

1.03

0.00 -3 63

Writing 2 (N = 65)

6.05

0.36-11.36

I 1.14

3.27-25.53

1.30

0 .00-4.58

Writing 3 (N = 66)

5 18

0.00-15 79

13. 12

5.08-21.74

1.44

0.00-4.55

Comb ined wr itings
(N = 200)

6 27

0.00-15.79

11.35

3.07-25.53

1.25

0.00-4.58

mean= 2.80%; negative emotion: mean = 2.02%). Participants utilized significantly
more positive emotion words than negative emotion words (t = 4.1 O;p = 0.00).
Furthermore, participants' use of positive emotion words increased across writing
sessions, but only reached significance for the difference between the first and second
writing session (writing 1 to writing 2: t = -2.94; p = 0.01; writing 2 to writing 3:
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t = -1.68; p = 0.10). The use of negative emotion words appeared to stay relatively
constant across sessions (writing 1 to writing 2: t = .29;p = 0.77; writing 2 to writing 3:

t = .53; p = 0.60). When averaging across all three writing sessions, participants utilized
more cognitive words (mean= 7.46%) than affect words. The use of cognitive words
also remained constant across writing sessions (writing 1 to writing 2: t = .18; p = 0.86;
writing 2 to writing 3: t = .08; p = 0.94).
The examination of verb tense revealed that the majority of participants
produced narratives characterized by more present tense words (mean= 11.35%) than
past tense (mean= 6.27%) or future tense words (mean = 1.25%) when averaged across
the three writing sessions. Analyses of change in verb tense over time indicated a
significant decrease in past tense verbs (writing 1 to writing 2: t = 3.84; p = 0.00;
writing 2 to writing 3: t = 1.97; p = 0.05), an increase in present tense verbs (writing 1
to writing 2: t = -3.16; p = 0.00; writing 2 to writing 3: t = -3.40; p = 0.00), and an
increase in the use of future tense verbs, which was significant only from the first to the
second writing session (writing 1 to writing 2: t = -2.17; p = 0.03; writing 2 to writing 3:
t = -.58; p = 0.57).

After determining the linguistic content of the narratives, analyses specific to the
second research question were performed. The second research question sought to
ascertain the relationship between the use of various linguistic variables (i.e., positive
emotion words, negative emotion words, cognitive words, and verb tense) and outcome
(i.e., PA, NA, intrusion and avoidance symptoms, general functioning). In order to
answer this research question, 2-tailed pairwise Pearson R correlations were conducted
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with seven linguistic variables and seven outcome variables, including the PANAS,
IES, and SIP. Some caution in interpreting these relationships should be employed due
to the large number of correlations conducted and thus, the increased risk of Type I
error. However, these analyses should be considered exploratory in nature and used to
provide truly preliminary infonnation on the relationships between outcome and
linguistic variables.
With regard to the PANAS, scor es from the NA and PA subscales were
analyzed separately (Table 34) . Positive emotion words were significantly positively
related to PA at 1-week posttreatment (r = .24; p = 0.05) . Negative emotion words were
found to be significantly negatively correlated with PA at 6-months posttreatment

(r = -.25; p = 0.04). The use of negative emotion words was positively correlated with
NA at the 1-week follow-up (r = .33 ;p = 0.01) . Analyses further revealed a significant
negative relationship between the use of cognitive words and PA at 1-year
posttreatment (r

=

-.263 ;p = 0.05) . Finally , the use of past tense words was found to

have a significant negative relationship with NA at 6-months posttreatment (r = -.24 ;
p

= 0.05), indicating NA decreases with the use of past tense words. No relationship

was found between NA and the use of cognitive words or present and future tense
words.
Analyses revealed additional significant relationships between linguistic
variables and avoidance and intrusion symptoms (Table 35). The use of negative
emotion words was found to have a significant positive relationship with intrusion
symptoms at 4 weeks (r = .32; p = 0.01) and 6 months (r = .26;p = 0.03) . The use of

Table 34

PANAS: Relationship Between Linguistic Variables and PA and NA
NA

PA
1 week

4 weeks

6 months

1 week

1 year

4 weeks

1 year

6 months

Linguistic category

R

p

R

p

R

p

R

p

R

p

R

p

R

p

R

p

Word count

.18

.14

.10

.43

-.13

.30

.08

.56

-.04

.77

.00

.99

-.02

.87

-.10

.47

Positive emotion

.24

.05*

-.02

.85

.05

.67

-.03

.84

-.06

.65

-.09

.49

.03

.80

.11

.44

Negative emotion

-.12

.32

-.12

.34

-.25

.04*

-.20

.15

.33

.01 *

.19

.14

.20

.12

.11

.41

Cognitive

-.14

.27

-.09

.50

-.03

.82

-.26

.05*

.07

.60

-.0 1

.96

.11

.40

.21

. 13

Past

-.01

.92

-.05

.69

.0 1

.96

-.08

.57

-.19

.12

-.02

.88

-.24

.05*

-.10

.46

Present

-.08

.52

-.05

.72

-.04

.73

-.10

.48

.18

.14

-.07

.56

.20

.12

.18

.19

Future

.06

.65

.06

.66

.06

.66

.14

.32

.08

.50

.14

.28

.06

.62

-.01

.96

Tense

* p-value

~

0.05.

........
0

N

Table 35
JES: Relationship Between Linguistic Variables and Intrusion and Avoidan ce Sy mptoms
Intrusion
1 week

4 weeks

Avoidance

6 months

1 year

I week

4 weeks

6 months

I year
--

Linguistic category

R

p

R

p

R

p

R

p

R

p

R

p

R

p

R

p

Word count

.04

.76

.00

.99

.08

.53

.12

.37

-.04

.77

.02

.86

-.05

.72

.02

.89

Positive emotion

-.14

.26

-.09

.49

.07

.59

.09

.53

-.07

.56

-.06

.64

.16

.21

.18

.18

Negative emotion

.10

.42

.32

.01 *

.26

.03*

.12

.37

-.01

.94

.14

.28

.15

.24

.10

.49

-.04

.78

.06

.66

.10

.41

.19

.17

.09

.45

.02

.89

.07

.58

.15

.29

Past

-.06

.65

-.05

.70

-.08

.52

-.11

.44

.01

.94

-.14

.25

-.27

.03*

-.27

.05*

Present

-.11

.88

-.00

.99

.02

.89

.01

.92

.04

.76

.12

.35

.25

.05*

.25

.07

Future

.16

.20

.04

.74

.13

.31

-.07

.60

.13

.31

.04

.73

.15

.24

.20

.15

Cognitive
Tense

* p-value :;; 0.05.

......
0

I.,.)
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past tense words was negatively related to avoidance symptoms at 6 months (r = -.27;
p

=

0.03) and 1-year (r = -.27; p

=

0.05) posttreatment. Furthermore , the use of the

present tense was positively related to avoidance symptoms at 6 months follow-up
(r

=

.25; p

=

0.05).

With regard to the SIP, specific linguistic variables were not found to be related
to household management activities or recreation and pastime activities (Tables 36 and
37). However , total word count at 4 weeks and 6 months was positively related to
mobility . The SIP score represents the percent of limitation in that area of general
functioning, indicating that as total word count increased limitation in mobility also
increased.

Prior Disclosure
Prior to answering the last research question, descriptive analyses were
performed on reported history of prior disclosure (Table 38). This measure consisted of
one question that asked participants to rate how much they had disclosed (i.e., through
talking or writing) their deepest thoughts and feelings related to their cancer and cancer
treatment. They rated their prior disclosure on a scale ranging from 0, not at all, to 10
compl etely. To summarize the rating scale into more meaningful and interpretable
categories, responses from O to 3 are interpreted as little disclosure, 4 to 7 as moderate
disclosure, and 8 to 10 as high disclosure. Just over half (53 .6%) of participants
indicated disclosing to a large degree prior to entering the study. One third (29.6%)
reported moderate disclosure and just over 15% said they had disclosed relatively little.

Table 36
SIP: Relationship Between Linguistic Variables and General Health (Part 1)
Household management
1 week

4 weeks

Mobility

6 months

I week

1 year

4 weeks

6 months

1 year

-

Linguistic category

R

p

R

p

R

p

R

p

R

p

R

.14

.25

.01

.95

.01

.93

-.14

.32

.13

.32

.24

Positive emotion

-.11

.39

.05

.72

-.16

.21

.12

.40

-.01

.92

Negative emotion

.10

.44

.03

.83

-.04

.76

.06

.69

.21

Cognitive

.06

.64

.07

.59

.06

.62

-.17

.23

.24

.06

.08

.51

.05

.67

-.01

Present

-.13

.30

-.01

.96

.08

.54

Future

-.13

.30

-.01

.96

.08

.54

Word count

R

p

R

p

.05*

.42

.00*

.02

.89

-.10

.45

-.10

.42

.02

.92

.09

.00

.98

-.14

.26

.03

.85

.04

.77

.12

.34

.00

.98

-.09

.52

.96

.07

.60

.14

.28

.15

.22

.15

.27

.01

.96

.02

.90

-.12

.34

-.06

.66

-.00

.99

.01

.96

.02

.90

-.12

.34

-.06

.66

-.00

.99

p

Tense
Past

* p-value

~

0.05.

.......
0

Vl
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Table 37

SIP: Relationship Between Linguistic Variables and General Health (Part II)
Recreation and pasttime
1 week

4 weeks

6 months

1 year

Linguistic category

R

p

R

p

R

p

R

p

Word count

.20

.11

.17

.18

.21

.10

-.01

.94

-.07

.58

.04

.78

-.09

.48

. 15

.28

.03

.82

.16

.21

.06

.63

.04

.77

.18

.15

.24

.OS

.15

.23

.00

.98

-.OS

.69

.02

.90

-.08

.54

-.1 S

.27

Present

.14

.28

.04

.77

.13

.30

.18

.21

Future

.06

.64

.01

.91

.03

.80

.10

.49

Positive emotion
egative emotion
Cognitive
Tense
Past

* p-value ::; 0.05.

Table 38

Summary of Prior Disclosure
DIS (N = 179)
Rating

n

%

0-3 (little)

30

16.8

4-7 (moderate)

53

29.6

8-10 (high)

96

53 .6

The final research question asked whether a relationship exists between
perception of prior disclosure at baseline and positive and NA (PANAS), general
functioning (SIP: Home management, mobility, recreation and pastimes), or traumarelated symptoms (RIES: Intrusion and avoidance) at baseline or follow-up. In order to
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answer this research question, history of prior disclosure was included as a covariate in
all previously presented linear mixed models. In addition, further exploratory analyses
were performed. Specifically, 2-tailed pairwise Pearson R correlations were conducted
with DIS and outcome, including PANAS, SIP, and RIES (Table 39). Results reveal a
significant positive relationship between perception of prior disclosure and PA at
baseline (r = .18, p

=

0.02), 1 week (r = .19, p

=

.01), 4 weeks (r = .17, p

=

0.02), and 6

months (r = .17, p = 0.03) follow-up, indicating that as perception of prior disclosure
increased so did PA. A negative relationship was found between perception of prior
disclosure and avoidance symptoms at baseline (r = -.21,p

=

0.00), 1 week (r = -.21,

p = 0.00), 4 weeks (r = -.22, p = 0.00), and 1 year (r = -.25, p = 0.00) follow-up,

Table 39

Relationship Between Perception of Prior Disclosure and Outcome
Time
I week
Outcome variable

4 weeks

I year

6 months

I week

R

p

R

p

R

p

R

p

R

p

.183*

.0 15

.188*

.014

.174*

.022

.165*

.034

082

.322

PANAS
PA
NA

-.131

.083

-.045

.562

-.057

.459

-.073

.352

-.115

.176

Hou sehold mgmt .

-.032

.674

.030

.698

.027

.726

-.020

.799

.084

.327

Mobility

.018

.814

.089

.247

-.06 1

.425

.037

.636

.017

.845

Recreation /Pastime

.050

.5 12

.013

.867

.034

.653

.066

.399

.054

.528

Avoidance

-.214*

.004

-.214*

.004

-.224*

.003

-.230

.003

-.251 *

.003

Intrusion

-. I 04

.168

-.104

.168

-.066

.396

-.077

.326

-.099

.245

SIP

RIES

* p-value

~

0.05.
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indicating that lower levels of prior disclosure are associated with increased avoidance
symptoms . No relationship was found between perception of prior disclosure and NA,
general functioning, or intrusion symptoms.
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CHAPTER V
DISCUSSION

The primary aim of the present study was to determine the effects of an
expressive writing intervention on the emotional and physical well-being of breast
cancer patients as compared to a treatment-as-usual control group. The secondary aim
of the study was to examine the linguistic content of expressive writing narratives. This
study specifically examined three research questions . The following presents a
summary ofresults, relates the current study findings to previous research , presents
implications and limitations of the project , as well as future directions .

Summary of Findings

The first research question asked, "Does an expressive writing intervention
impact PA, NA, intrusion and avoidance symptoms , or general functioning as compared
to a general health information control?" In order to answer this question , a series of
linear mixed models were conducted. Results revealed a significant treatment effect for
PA , indicating that the EW group evidenced significantly greater improvement in PA
over time in relation to the GHI group. The GHI group also showed significant
improvements in PA across time. No other intervention effects were found for the other
outcome measures. However, analyses revealed that individuals in both the EW and the
GHI groups reported significant improvements on all outcomes over time , including
NA , intrusion and avoidance symptoms , and general functioning (home management,
mobility, recreation and pastimes). Based on this finding it is difficult to determine
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whether participants felt better as a function of time, or whether they evidenced
improvements as a result ofreceiving the EW and GHI interventions. Unfortunately,
without having a nonintervention or neutral writing control, this determination cannot
be made. This will be discussed in further detail later in the discussion. With regard to
the covariates examined within each model, several significant effects were found.
Specifically, more advanced breast cancer was associated with lower PA , higher NA,
and greater limitation in home management and recreation and pastimes. It should be
noted that participants within the study had stage I, II, or III breast cancer (individuals
were excluded from the study if they had stage IV cancer). Therefore, "more advanced
stage cancer" is specific to participants of this study, as opposed to individuals with
stage IV (advanced stage) cancer. Moreover, it appears that individuals with more
advanced breast cancer tend to experience overall decreased psychological well-being
and have a lower level of general functioning. Additionally, perceived prior disclosure
at baseline was found to be related to positive long-term effects on measures of
psychological well-being. Specifically , a greater history of prior disclosure was
associated with higher PA, and a smaller degree of prior disclosure was related to the
experience of more avoidance symptoms . Younger age was also associated with greater
intrusion symptoms. Having a history of participating in previous therapy was
associated with decreases in limitations in the areas of home management, mobility, and
recreation and pastimes across time . Lastly, having a higher level of education was
related to decreases in limitations in home management.
The second research question asked, "What are the relationships between the use
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of positive words, negative words, cognitive words, and verb tense across the three
writing sessions with PA, NA, intrusion and avoidance symptoms, and general
functioning?" Analyses indicated few and inconsistent relationships. For instance, the
use of negative emotion words was negatively related to PA at 6 months, and positively
related to NA at 1 week. This suggests that the use of negative emotions words is
related to decreases in PA and increases in NA. This is as would be expected in that
one's choice of emotionally charged words seemed to reflect one's emotional state (or
vice versa) . Findings also indicated that NA tended to decrease with the use of past
tense verbs . PA also tended to decrease with the use of cognitive words. With regard to
intrusion and avoidance symptoms, the use of negative emotion words was related to
increases in intrusion symptoms. The use of past tense verbs was also related to
decreases in avoidance symptoms, whereas the use of present tense verbs was
associated with the increase of avoidance symptoms. Concerning the relationship
between the primary linguistic components analyzed and general functioning , no
significant relationships were found. The relationship between linguistic variables and
outcome measures should be interpreted as preliminary and exploratory, due to the large
number of correlational analyses that were conducted and due to the inconsistent
findings across time (i.e., significant relationships were often found at only one of the
four postintervention follow-up periods). Overall, they should also be interpreted with
caution.
General descriptive linguistic analyses revealed that the use of PA words tended
to increase across writing sessions, whereas the use of NA words and cognitive words
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tended to remain constant across the three writing sessions . With regard to verb tense,
the use of past tense verbs decreased across writing sessions, but the use of present and
future tense words increased . Overall, participants utilized more present tense words
than future or past and more future tense words than past tense words.
Finally, the third research question asked , "Is perception of prior disclosure at
baseline related to intrusion and avoidance symptoms, PA, NA, or general functioning
at baseline and follow-up?" This question was primarily answered within the first
research question , as prior disclosure was included within each linear mixed model as a
covariate . However, results will be briefly reiterated here. Overall, perceived prior
disclosure at baseline was found to be related to positive long-term effects on measures
of psychological well-being (i.e., PA , avoidance symptoms) , but not related to general
functioning. General descriptive findings revealed that most participants reported a
history of disclosing thoughts and feelings related to their cancer experience. However ,
up to one third of participants had only moderately disclosed up to that point , with 15%
disclosing very little to not at all.

Integration of Current Findings and Related Literature

The majority of existing expressive writing studies focusing on patients with
general cancers , found no effect of an expressive writing intervention on psychological
well-being (de Moor et al., 2002 ; Rosenberg et al., 2002). However, these studies
utilized predominantly male participants. One study utilizing relatively equal numbers
of males and females found the expressive writing intervention to be related to a
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decrease in avoidance behaviors at 6 months postintervention (Zakowski et al., 2004).
Unfortunately, the researchers did not assess affect. Studies examining the impact of
such an intervention on breast cancer patients revealed positive effects on physical
health (Stanton et al., 2002), but no effects on psychological well-being (Stanton et al.;
Walker et al., 1999). Overall, previous research continues to be mixed with regard to the
impact of expressive writing on psychological well-being. However, it is important to
note that , aside from the contrasts in gender across most previous studies and the
present project, the studies that found no impact on psychological well-being utilized a
low number of participants (N = 15-21) in each intervention group (de Moor et al.;
Rosenberg et al.; Stanton et al.; Walker et al.). This may have also impacted the ability
of their findings to reach statistical significance. The present study adds to the
controversy of findings in this area in that the expressive writing intervention was
significantly related to increased PA over time , but umelated to intrusion and avoidance
symptoms . Individuals who were randomized to receive the expressive writing
intervention reported significantly greater postintervention gains in PA as compared to
the GHI group. Differences were consistent even when controlling for a variety of
covariates (i.e., age, cancer stage, previous therapy, marital status , education, prior
disclosure) that were thought to potentially influence outcome. Further research is
needed to help clarify whether women with breast cancer can gamer benefit from
expressive writing and in what specific domains (e.g., psychological well-being,
physical health, general functioning) may be impacted by such an intervention.
With regard to linguistic trends, the present study found an increase in PA words
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across sessions, but no change in NA words. Despite future research being warranted,
these findings may help to somewhat resolve contradictions across previous studies.
That is, Pennebaker (1993) found participants who evidenced health improvements
utilized a larger proportion of negative emotion words (i.e., anxiety, sadness) than
positive emotion words as compared to participants who did not improve. However, that
finding is not only contrary to the present study's findings, but is also contrary to two
other primary studies that have employed linguistic analyses in the context of
expressive writing (Pennebaker & Francis, 1996; Pennebaker et al., 1997). For instance,
Pennebaker and colleagues found that the use of positive emotion words was related to
better health. Pennebaker and Francis also found that the more positive emotion words
participants used, the better their health after the writing intervention. Based on
previous research, one may speculate that the present study's finding of a significant
relationship between the use of positive emotion words and PA and the finding that the
use of positive words increased over time, may have impacted the significant increase in
PA across the year of follow-up. However, additional research on these relationships is
warranted.
The current study found no changes in the use of cognitive words across writing
sessions, which is in direct conflict with the most consistent linguistic finding reported
in existing studies. Researchers have specifically reported positive outcomes to be
related to an increase in the use of cognitive words across writing sessions (Pennebaker,
1993; Pennebaker & Francis, 1996; Pennebaker et al., 1997). However, these studies
utilized physically healthy participants. Low and colleagues (2006) examined the
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linguistic content of expressive writing essays in a breast cancer population and found
no significant changes in the use of cognitive words across writing sessions. The present
study found the same result. The failure to find an increase in the use of cognitive words
with breast cancer patients could be due to a variety of factors. First, it may be related to
the trauma about which the participants wrote. That is, it may be inappropriate to
compare findings from a study that examined expressive writing about one's transition
to college or about being laid off of work, for example, to studies that examined
expressive writing about one's breast cancer experience . The topic about which one
writes may help to dictate the specific linguistic components that lead to positive
outcomes. However, this warrants further study. Furthermore, it can be hypothesized
that the mere physical condition of having breast cancer, may impact how and what
participants write about, particularly when compared to healthy controls. Lastly, it
should be highlighted that this study did find that participants used significantly more
cognitive words than affective words, which indicates participant's essays were at least
in part focused on cognitive processing.
The use of verb tense has not been widely examined in expressive writing
literature. However, despite few researchers examining this domain, findings seem to be
consistent across studies, including the present study. Pennebaker and Francis (1996)
also found a decrease in the use of past tense words across writing sessions in a similar
study examining a sample of college students. Walker and colleagues (1999) found a
decrease in past tense words and an increase in present and future tense across writing
sessions as well. With regard to the present study, participants utilized more present
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tense verbs than past or future tense verbs. A decrease in past tense verbs and an
increase in the use of present and future tense verbs across writing sessions was also
noted. Furthermore, the use of past tense verbs was associated with a decrease in
avoidance symptoms . Participants were in the process of completing radiation therapy
for their breast cancer upon entering this study. Given that they were at the end of that
treatment, and in light of the present findings, it could be hypothesized that the use of
past tens e verbs indicates participants may have been confronting or disclosing about
previously avoided thoughts and feelings . Once this disclosure took place, it logically
follows that they might progress to writing about thoughts and feelings related to the
present time or future. However, again it should be noted that given the exploratory
nature of the analyses, such hypotheses and conjecture should be interpreted as
preliminary and contingent upon further study.
Finally, little research exists that explores disclosure patterns among breast
cancer patients . However, findings from the present study are commensurate with the
results of previous investigations. Generally, findings from the current project indicated
that over 15% of participants reported having disclosed relatively little prior to entering
the study. This finding is consistent with existing research that reported 15-23% of
breast cancer patients had disclosed little to family , friends , and medical professionals
(Henderson et al., 2002). The current project found that having a history of prior
disclosure was associated with increased PA across both treatment groups. Conversely,
a history of little prior disclosure was associated with avoidance symptoms. These
findings suggest what would be expected based on trauma and inhibition theories
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(Chemtob et al., 1988; Foa et al., 1989; Horowitz, 1986; Pennebaker & Beall, 1986);
that is, the more one discloses about a distressing event the better one feels, and the
more one inhibits thoughts and emotions related to such an event the more one
experiences related avoidance symptoms. Furthermore, in breast cancer patients
research has demonstrated that inhibiting one's thoughts and feelings related to having
breast cancer is associated with breast cancer metastasis and with an earlier death
(Jensen, 1987; Weihs et al., 2000) .
The present study found a significant effect over time for both the EW and GHI
groups across all outcome variables. This study also collected data longitudinally for 1
year postintervention, which is the longest longitudinal study in this area of research.
One reason the present study may have found significant effects over time is due to
collecting data over a longer follow-up period . Prior studies examining the effect of
expressive writing on breast cancer patients collected data longitudinally , but for 7
months maximally (Walker et al., 1999). The majority of changes in psychological
well-being that were detected in the present study were not apparent until approximately
6 months postintervention. For instance, sharp increases in PA were not found until 6
months posttreatment. With regard to intrusion and avoidance symptoms , participants
did not evidence substantial declines in symptoms until 1 year posttreatment. If
participant change was not measured up to 1 year postintervention, the positive changes
observed may not have been detected. Furthermore, the patterns of change over time
may look different if not measured longitudinally. For example, participants reported
decreases in NA at 1 week posttreatment, with little change from 1 week to 6 months. If
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the follow-up assessments had stopped at 6 months, then the sharp decline in NA from
the 6 month to the 1 year follow-up would have gone undetected. The trajectory of
change for NA would have appeared to represent an immediate improvement in
symptoms and then a leveling off trend, as opposed to what actually occurred, which
was additional improvement in symptoms after 6 months. It seems that measuring
participant change longitudinally for at least 1 year was beneficial in revealing
potentially more accurate changes in functioning over time .

Limitations

Both the participants, who received the EW intervention and those who received
the GHI intervention , evidenced significant improvements on all measures of
psychological well-being and general functioning across time. This overwhelmingly
positive finding points to a potential flaw in the way the two groups have been
described and a potential threat to internal validity. The EW group was considered the
treatment group and the GHI group was originally described as a treatment-as-usual
control. However , analyses seem to reveal that the GHI may , in fact, be more accurately
described as a treatment itself. Breast cancer patients are typically provided with
general information about what to expect posttreatment and where to find resources
related to breast cancer and its treatment. However, the GHI group received detailed
information via audiotape and were provided with a written copy of the information that
they were instructed to read on the following consecutive two days. Based on the way
this information was disseminated to patients as well as the detail included in the
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information, it is speculated that the GHI potentially functioned as a treatment. It
appears that both interventions were related to positive effects in participants over time.
Unfortunately, these results can only be described as being associated with outcomes
and warranting further study. Due to not having a true nontreatment control group, it is
impossible to determine whether participants' improvements in psychological wellbeing and general functioning were due to the treatments themselves or to the passage
of time , or some other threat to internal validity . Therefore , a major limitation to this
study is the control group utilized. Cleaner comparisons could have been made if either
a wait-list or no-intervention control group was utilized. A neutral writing control group
would have also helped to make more descriptive comparisons. Researchers, who have
utilized a neutral writing control group, have been better able to make assumptions
about the effects of the expressive writing intervention (Francis & Pennebaker , 1992;
Greenberg et al., 1996; Pennebaker et al., 1990; Pennebaker & Francis , 1996). The
neutral writing control is typically instructed to write about an innocuous subject (e.g.,
describe the room you are sitting in, write about your plans for the day). By utilizing a
neutral writing control, the participants are essentially engaging in the same task, but
with a different focus, making assertions about causal versus correlation effects easier.
Two additional threats to internal validity have been identified. First,
participants were studied over 1 year of time. During that year, which occurred
postradiation treatment, participants would have had time to potentially mature or grow
emotionally and cognitively. This growth or maturation would be particular to having
completed treatment for a life-threatening illness. Additionally, it is possible that
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participants experienced or were exposed to something during the year of follow-up
assessment that impacted their psychological well-being or general functioning and that
affected outcome. However, participants in both the EW and GHI groups experienced
similar changes over time suggesting that if they had matured or experienced a
confounding event , it did not differentially impact outcome.
The outcome data for this study was entirely based upon self-report measures
and did not include measures of physical health . Having some objective measure of
adjustment that could either be corroborated or be obtained independently of
participants may have added a level of objectivity to outcomes . However, it is noted that
all self-report measures utilized had adequate reliability and validity . Measures of
physical health (e.g., medical visits, blood pressure, heart rate) have been demonstrated
to be useful objective measures of adjustment. In fact, expressive writing has been
found to positively impact physical health , emphasizing the importance of including
such objective measures of adjustment (Greenberg & Stone, 1992; Greenberg et al.,
1996; Pennebaker & Beall, 1986; Pennebaker et al., 1988; Petrie et al., 1995).
In addition , this study was interested in determining the effects of prior
disclosure on outcome in order to determine who might most benefit from such an
expressive writing intervention. It may have been even more informative if perception
of disclosure was also measured after each of the writing sessions . This may have
provided information about the extent to which participants perceived they disclosed
during their writing, which in tum may have illuminated the depth of disclosure
necessary to produce positive outcomes.
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Finally, with regard to external validity, several potential threats exist. First, the
majority of participants in the present study were Caucasian. However, this is
characteristic of the region of the country from which participants were sampled.
Furthem1ore, it appears to be typical based on other studies utilizing breast cancer
patients (Stanton et al., 2000, 2002; Walker et al., 1999). The majority of participants
were also married and had at least a high school education (with many having graduated
from college). These sample characteristics are also typical of existing research (Stanton
et al., 2000, 2002; Walker et al.). With regard to cancer stage, the majority of
participants had either stage I or stage II breast cancer with very few having stage III
cancer. Research has demonstrated that individuals with more advanced breast cancer
experience similar rates of depression and anxiety (Kissane et al., 2004), but experience
higher incidence rates of PTSD as compared to individuals with earlier stage cancer
(Andrykowski & Cordova , 1998; Andrykowski et al., 1998; Cordova et al., 1995;
Jacobsen et al., 1998). Consequently, generalizing results of the present study to
individuals with higher than a beginning- to middle-stage breast cancer (stage I, II, or
III) , warrants further research. In addition, all subjects participated in this study at the
end of their radiation treatment. The time immediately following completion of
radiation treatment was chosen for this intervention study because it has been found to
be characterized by distress (Jarrett et al., 1992; Maher, 1982; Walker et al., 1996).
However, this indicates that generalizing results to breast cancer patients who are in a
different phase of treatment or recovery warrants additional study.
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Implications

Research has revealed that most women with breast cancer have at least
somewhat discussed their disease with others. However, many disclosed relatively little
(15-23 %) with others (Henderson et al., 2002). This finding is consistent with the
present project. Furthermore, previous research indicated that more than half of
participants wanted at least moderately to discuss their experience with others .
Conversely, 19% of women said they did not want to talk about their experience at all,
and 12% at least somewhat wanted to keep their breast cancer a secret (Henderson et
al.). It appears that most women with breast cancer disclose their thoughts and feelings
to others . However, there is a subset of women who do not disclose to others and a
subset who do not want to discuss their experience with other people . It seems that this
expr essive writing intervention is unwittingly tailored specifically to individuals who
may not want to express their thoughts and feelings about their breast cancer experience
to others . The writing paradigm provides a confidential , private , outlet that can be used
to express oneself without the pressure and uneasiness one might feel if discussing such
a sensitive topic with other people .
Researchers have demonstrated that the inhibition of breast cancer-related
thoughts and feelings has been associated with cancer metastasis (Jensen , 1987) and
with a shortened survival time in recurrent breast cancer patients (Weihs et al., 2000).
This grim finding is even more worrisome, provided the number of breast cancer
patients who do not want to discuss their experience with others, including those who
want to keep their experience a secret (Henderson et al., 2002). However, the
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expression of cancer-related thoughts and emotions has been associated with positive
physical and psychological consequences (de Moor et al., 2002; Low et al., 2006;
Rosenberg et al., 2002; Stanton et al., 2002; Walker et al., 1999; Zakowski et al., 2004).
Based on this body of literature, it logically can be concluded that breast cancer patients
should be encouraged to express their thoughts and emotions specific to their cancer
experience and should be provided with a means to do so. Expressive writing is a
confidential, noncost prohibitiv e, easy intervention that to date has not evidenced any
contradictory findings that would not support providing such an intervention to breast
cancer patients. One might argue that taking 20 to 30 minutes out of one's day to write
about a potentially emotionally difficult subject could be taxing to the average breast
cancer patient, particularly if she is experiencing treatment side-effects (e.g., fatigue;
King , Nail, Kreamer, Strohl, & Johnson, 1985). However, it may be speculated that the
potential long-term benefits (e.g., increased PA, decreased negative physical symptoms,
decreased medical appointments; Stanton et al., 2002) of the intervention outweigh the
potential short-term uneasiness that may result from confronting something that may be
emotionally difficult.

Future Directions

It is evident that expressive writing is not only likely beneficial for physically

healthy individuals, and has also been demonstrated to be potentially beneficial for
individuals with breast cancer. However, findings remain mixed with regard to the
specific areas of functioning (i.e., psychological well-being, physiological functioning,
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physical health) that expressive writing can impart positive effects. Future research
should employ a range of self-report and objective measures examining multiple areas
of functioning and adjustment in order to accurately assess how expressive writing can
impact breast cancer patients.
Similar to the limitations of the present study, it is recommended that future
studies examining the effect of expressive writing on breast cancer patients employ a
true control group or neutral writing comparison group. Furthermore, using at least one
objective measure of adjustment, particularly a measure of physical health when
examining expressive writing in breast cancer patients , is recommended.
A systematic review of expressive writing studies utilizing physically and
psychologically healthy participants found that those studies that spaced writing
sessions across a longer time period evidenced more significant outcomes (Smyth,
1998). The present study had participants write on 3 consecutive days. Despite the
present study examining breast cancer patients, as opposed to healthy individuals as in
previous research, further examination of the effect of spacing expressive writing
sessions across a longer time period is warranted.
The present study sought to extend the existing and extensive expressive writing
literature, which has primarily focused on healthy participants, to a breast cancer
population. Few expressive writing studies have collected data longitudinally. This is
the first study in the area to collect data up to 1 year postintervention. The significant
treatment effect on PA at 1 year postintervention, as well as the significant positive
effect over time on all outcome measures, points to the importance of studying the
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effects of expressive writing interventions longitudinally. This example of longitudinal
research design will hopefully provide a jumping off point for future research on
expressive writing.
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gsc rib e c oncise ly the resear ch design and methods for achieving these goals. Avoid summaries ot past ac;compfishments and use of the first p erson.
""'lisdescription is meant 10 serv e as a succinct and accurate description of the proposed work when separated from the .application. If the
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Thn randomized clinical trial tests two means of facilitating the adjusunent of breast cancer (BC) patienrs
(St.ages I, II, and III ) during an in.frequently srudied bur critical tim.eframe-post-radiation therapy (RT). The
majoriry of women diagnosed with BC receive RT but little nursing research is aimed at understanding and
facilitating the coping processes following the common experience of RT. This project will provide the first
critical comparison of two theoretically derived interventions which target the post-RT-coping processes of
women with BC. The two interventions, which we have pilot tested, target the instrumental and emotional
coping functions specified by Levantbal's self-regulatory theory. First, Concrete Objective Information (COI)
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fostrnctions to Sll!bjects in
EE foterventioro

As I mentioned earlier, our study is comparing different ways of helping people cope with the
experience of cancer and cancer treatment. The program that we've developed for you is

something new and promising. This program involves writing about your feelings. What I'd like
you to do is to spend one-halfhouir each day during three of these next four or five days writing
you might choose to write today, tomorrow, and the next
about your experiences. For exl!.rt1ple,
day; or you might write today, s!ci!Ptomorrow and write for one-half hou r the following day and

the dlay after that.

During the first session, and again on the other two days you write, I want you to spend thirty
minute s writing. Let go and write about your very deepest thoughts and feelings about your
cancer and cancer treatment. I'm sure I don't need to tell you that cancer and cancer treatment
can be a tra umatic experience for many people. Sometimes it's awkward or difficult to discuss
your feelings with others. We believe that writing about them might be a good way of working
through analsorting out these strong and complicated emotion s. m your writing, you might want
to write about your feelings about your diagnosis, the impact of the disease on your personal
relationships, or your feelings about radiation treatment.

Don't worry about your grammar or spelling. These aren't important . What is important is that
you write for the who le thirty minutes about your deepest thoughts and emotions, especially those
that you might not have talked about \1/ithanyone. Really try to dig down into your thoughts and
feelings and explore them in your writing.

When you are writing at home, if you prefer to use a word processor or typewriter, please do so.
After you finish wtiting on each of these days, ple:ise comp lete the !-page questionnaire asking
about your mood. Put all materials in rhe envelope provide d, seal it, and bring the packet w ith
you when you come for your clinic visit on your last day of tre:itme:it. One of the rese:irchers will
meet you at the clinic to pick up the envelope.
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Day 2
Date.____
_
Pleaseuse the pages providedto write aboutyour deepestthoughtsand feelingsabout your cancerand
cancertreatmentespeciallythose that you mightnot havetalkedabout withanyone. lfyou prefer,you
can use a word processoror type writer. Do not worryaboutgrammaror spelling. What is most
importantis that you write for 30 minutes. At the endof the halfhour, completethe attachedrating

form.
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Appendix C
General Health Information

Things to Remember as Treatment

Ends

POST RADIATION TREATMENT COPING PROCESSES
RESEARCH GRANT
UNIVERSITY OF UTAH
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Gt::iera.lEdth lvfessage

Tnis me:;s;:.geis designed i.Ogive you informadcn Jbcut rescurces available to you
anci things that you do now that your radiation the:c.pyis e::ciing. Ove:-the pas, few ye1rs,

the way people ge-::informationabout c..nce:-and C:l!lcertre::it!Ile:::t
hasc:ianged. i\,fany
organizations, like the Natonal CJI1ce:-Institute and the A,-nencan.
Cance, Soc:ery,have
information availableby ~ompute:-,by telephone, and in print. Both the American Cance:Srn;ety and the National Cmce:-In.srimteprovide telephone uurnoe:-sfor people to call
who have questions about cancer-.local units of the .A..merican
Cance:-Soc:ety also
provide a variety of se:vices for c.:mce:patients and maintainlibrariesof readir1gmate::ials.
Telephone numbe:-s,Internet compute:-address information, and the address of the nearest

Ame::ican Can~ Soc::etyUnit are !i~ed in the infor.mat:ion
sheet that gees aiong wirh this
tape.

Both the Arneric:m Cance:-Socety and the NatioD.2.1
Cance:-I.u.st.irute
produce
v1ritte:i materials for cancer patie:m. You can access these mzte:-ialsby calling the

appropriate org;n:iT>riou.Other sources of in.format.enB:orubocks er articles fer c:i.nce::

patie:its inc!ude public fforaries,bcc~cres, liorc.riesat coilegesa.nd1m.ive,sitieswitli
sc:10olsof medicineor nursing,and ti:i.eNational Cz.r;ce:Instirutes. Many pcpular
mag-::f:ies puoiis.i:!
3.rcic!esabcut c::.r:ce:a.sweU. y cur led pu.oiicliora.c-fis 1 geed pi2ce
to loc:.re t.'lesearcic:es.
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something you won't forger, it is a good ide:! to keep this information in writte:i form.
You will also want to write down the ']'Pe of c:mce:-you have, whe::i it was diagnosed, and
the month and ye3! whe::i you finishei ::re:u:me::1t:.

Tne s+<afi'
at the tre:i.tme::it
se~g will provide you with information about
sc:ie::lul.ingyour follow-up appoincmems. Some patie:1ts continue seeing the doc:ors and
nurses from the radiation the.rapyceme:-for some time. Othe:-s go back. to their He:ilth
.i\fa.intenance Organization or prim,iry w.re provider for their follow-up care. The

arrangements re--..ommended
to you v.-iildepe:id upon the usualpractice followed in your
tre:itme::it ce:iter and the a.mmge:ne:rt the c:!!lter has with your he:i.lthinsurance company.

If you find that you will be movingout of the area and have bt!!!n getting follow-up care at

make S'..U-e
to find out if the people h~e re::ummend that
the radiation tre3tment c::::Jter,
you contact a radiation tre:itmot center in your new loc:;.tion to arrange your follow -up
care.

At

~c::r.
follow-up

vi.sit,Ill2.kesure you understand what tests , if any, you need to

mm.endeddepe:tds upon the type of
have done before the ne:CTvisit. The type oftes. f(Y-O
c:mcer you bad, how your tre'.ltme:::t we::it, and your othe:- metlic:tl proble:ns.

You may or

may not have things li\e routine biood test.s sc::1eduledas part of your follow-up c;u-e.
The schedule of foiloW""'JP
visirs ibo de 7e::1dson a lot of dirre::e:rt fac:ors. If you
find thar follow-up vi.sirsare be:..':g912:!!e:iat ti..""!les
wiJ.e:i :,cu 'Nlli be on an e~e=ded trip
er ii you spur your time ~e,;vee:: ~'us ::e:i :nci mcme:- place , cfoc:.1ssyew- usuai tr3.ve:

hc.Qits·:viti.1;:he pe:,pie a ,i:ie ,re::::...--;-.e:::
::c:::-.,e~
,o :ie,e:-r.jl'.e ;f your foilow -:.1pvisi,s c:m be
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Rc:nembe:-to ke~;i tr.le:(of c.:iangesin your me:iic:irions or any new he:!lth
problems so you Qn update your doc:or at e:1c:1visir. If you have compiica:cd
medic:nions, it is alwavs a g:oodide:i to bring the bottles of pills to all your _,;..:;i:s.
1,hle

sure that all your decors know about e::i.c:i
othe: so they can sh.are information.

--

You willalso want to be sure ycu know who to contact at the Radiation
Tre:mne:1t Centerin case :t<Jt!
have quemons about any bills or state:::ie::xts
you or your

insuranc~ c::irnparz:,
re:~

after your treatme:J.tis c0mpletd. You can get this

information at the m:epticn desk ifit is not on any cfrhe information sheets ycu re~6:e:i
at the radiation tre:itme::t ce!lter.
Ycu will also want to be sur! you are ta.'lcingfull advantage ofrhe insurance
coverc:cgeyou have. M2.nypecple don't know about all the be::efus the; are e!ltitled to so

it is a good to leek over your po!ic-Jto make sure tba.t you are submitting ail the bills you
shoulG. If you have quemons about your insurance coverage, che::( with your employer's
ber:efhs office or your insur..ncecompanyfor assistance in inte::pre-::ing
your bene.5ts.__E
ycu hc.ve conce:ns about iter:LS
your insurance company is or is not paying, you can
cont.ac: ne radiation trc:!blent ce:1~.:::so they can se::d in a c!aim that was turned down so

it ge-..sre·,i ewed agmn. Yocr doc!cr m:i.yneed to write a letter to explain cnything that
w:,.s

unuxtl aboutyour tre~tme::,. Y-::iu·;vi] need to c:mt2.c: the do~or-to disc:rss tb..:.s.

Toe lcc:tl ·Jnit of che,<l_,.:ieic:ll C3.nce::Scc:e:y .:::.nhe:p you :de::itifywhic:. age:1c::in you:s:c..te:-egi-1la:e
s ~~ur~ce c~rnp~es

IT you find

t.hz.tycu :ie~~ to file

J. c~mpi2l.!"'IL
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you are imerestd in a voiumee:-cppolluniry, you c:m comae: the loc::.iunit of the
Ame:ic:ui Cane:=:-Soc:.ecyor the voiuncee:-office :it your loc:tl hospid or at the insrirurion
wne:-e the tre:itrne:it fac.liry is loc:ited. Ame~c:in Cance:-Soc:e:y volunteers fill

:i

vane~;

of jobs. The!:.einc:ude stuffing e-:ive!opesand an.swe::ingte!e?hones, givingout
inrorma.cionover the te!ephone about resources in the community,se:ving on the Board of
Directors oi the Ioctl group, or giving public education programs at meetingsin the
community. Hospital voluntee:s rnay he!p transport patients, de!ive::flowers and mail,
greet patients and visitors, assi..'iwith pape.-work, or se:ve as visitors for patients in the
hospital. You may find that the:-eare other organizations in your area whica can use
voluntee::s to help transport people who do not drive to medical visits,_spe::1dtime with

-

p~ple at home, deE:verequipme::Jt,or make sure that people get a hot me:i..l.
If you have questions about the mate:-ialin this tape, pie:i.seask the:n once you tell

the pe.""Sonwith you that the tape is fini.5hed.
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SubJ II_____
lntcrvcmion ---

Medical Record#---

Consent __

-------

---

____

ln1ervcn1ion --

Baseline____

--

---

Participant Screening Form
Post-Radiation Treatment Research
\amc

Date Screened -----Phone

:\ge

Researcher Initi:ils

Dx Date --

--

Agreed to Participate __

-------

-------

-----

Time of Appl

-----------

Family Histor)' ------

--

Refused __

-

(if stated, note rea son)

-------

Clinic Site

StM

UH

COH ~ ___

J

LDS s

Cottonwood

Physician --------------------

TxStan

Date _____

·------

Confirmed Date _______

_______

T:c F.nd Date

--

_ In eligib le Criteria

Duration

Under 21

Dose
Stage---Tumor

--------

--- -----------

Node
_Chcmo

A.,

S1c111( di

h

Bone \[ 3rro"

_

T:irn

Other lllnesscs or Condiri ons

\k dir:11ion, ___

Stage O

3_

Stage JVf}lct s

4_

Un3ble to ·pc:i.k, write, or read English

5_ Rccci, ·ing psychiatric care

C.--\Trc :1tmcnt :
M:ist 5

2_

_ _______

_ __

__

__

6

Substanc e abuse

7_

Not independent

8_

Li, in\! in 3n insti1ution3I scning

~-

Co;:ni ti,c deficit

in , df

c ir ('

ifl

Pr e, inus r :1dL11i
on rrca1111c111

lI_

Pr c, iuu, C.\ (c,ccpt skin )

_____

____________

_

.
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Subj# __
_
Data Line __

_

Tx end date-----

Baseline Demographic

Questionnaire

Directions:
Please answer all of these questions accurately. The information you
provide will be used only for this project and will not be seen by anyone else.

I

1. Today's date:

2. Your age:
3. Your race or ethnic background:

__

years

10 Asian or Pacific Islander
20 African American
3Q Caucasian

40 Native American
50 HispanidLatino

60 Other
4. Your marital status:

---

----

10 Single (never married)
20 Separated or divorced
30 Widow
JO Manied
sO Cobabitating

5. Highest grade of school completed:

10 8th grade or less
20 Some high school
.30 High school graduate/GED
40 Technical school graduate
sO Some college
60 College graduate
10 Master~ degree
sO Doctora!e degree

6. Your employment status:

IO Full-tirne(30hours per \\e ek or more)

20 Part-time
; 0 Homemaker
JO Unemployed
sO Retired
GD Disabled
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7. What is your religion?

10 LDS
20 Catholic
30 Protestant (Christian)
40 Jewish
sO Other
(if you checked any of the above
boxes, answer 7a)

60 Not a religious person
7a. Do you consider yourself to be an
active or inactive member of your religion?
(Byactive, we mean that you attend services
regularly).

10 Active
20 Inactive

(#of people in household)

8. How many people, including yourself, (live in
in your household?

__

9. Have you been hospitalized within
the past six months?

1DYes
20

No (skip to ~10)

9a. If yes, what was the
reason for your hospital stay(s)?
10. Have you seen a counselor (therapist,
psychiatrist, psychologist, social worker)
at any time since you have been diagnosed
with cancer?

l Oa. Was the counseling focused on issues
related to cancer or was it primarily focused
on other issues?

10 Yes
20

No (skip to #11)

10 Cancer-related
Other issues

20

l Ob. Indicate the approximate number of counseling
sessions you have had since being diagnosed with cancer.
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l I. During the past seven days, how often have
you worried about your cancer?

1CJ Not at a11
2CJ Rarely
Sometimes
Much of the time
sCJ Nearly all of the time

3(J
4(J

12. Do you suffer from any other illness or conditions
besides cancer ? (e.g., hypertension, multiple
sclerosis)

1CJ Yes
20 No

(Ify es,mswerl 2l )

l 2a. Please list all other illnesses or conditions:

13. Please write the month and year you were first diagnosed with breast cancer.
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PANAS Questionnaire-(State)
Directions: The words listed below describe different feelings and emotions.
Please read each item then circle the number that indicates how much you
have felt that way in the past few days.

l=not

at all

2=a little

3 =moderately

5 = extremely

4=quite a bit

1. Irritable

1

2

3

4

5

2. Alert

1

2

3

4

5

I

2

3

4

5

4. Inspired

I

2

3

4

5

5. Nervous

1

2

3

4

5

6. Jittery

1

2

3

4

5

7. Active

1

2

3

4

5

8. Afraid

1

2

3

4

5

9. Guilty

1

.2

3

4

5

10. Interested

1

2

3

4

5

11. Distressed

1

2

3

4

5

12. Excited

1

2

3

4

5

13. Upset

1

2

3

4

5

14. Strong

1

2

3

4

5

15. Enthusiastic

1

2

3

4

5

16. Scared

1

2

3

4

5

17. Hostile

1

2

3

4

5

18. Determined

1

2

3

4

5

19. Proud

1

2

3

4

5

20. Attentive

1

2

3

4

5

3. Disgusted
with myself
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Baseline questionnaire instructions
Before beginning this questionnaire , please read the following instructions .

You have certain activities that you do in carrying on your life. Sometimes you do all of these
activities . Other times , because of your present illness you may not do these activities in the
usual way, you may cut some out; you may do some for shorter lengths of time; you may do
som~ in different ways. We are interested in learning about .fil1Y
changes that describe you
now and are related to your present illness.

In this questioMaire there will be a good number of statements about how people's health
could affect their lives. Read all the statements . Thinkcarefully about the statements and be
sure to check those problems you are experiencing now ..When you read a statement that
applies to you, describing how your present illness is affecting your daily life, please check it.

To explain further, we have provided you with an example. You might read the statement "I
am not driving my car." If this statement can be answered "yes" because of your health and
de scribes you today, you should check it. Also, if you have not been driving for some ti.me
because of your present illness, and are still not driving today, you should respond to this
sta teme nt.

On t he other hand, if you never drive OR are not driving today because your car is being
repaired, the statemen~ "I am not driving my car" is not related to your health and you should
not respond to it. If you simply are driving less; or are driving shorter distances , and feel that
the statement only partially descnoes you, please do not respond to it.

Remember , we are interested in recent changes in your activities that are related to your
pre sent illness .
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This group of statements has to do with any work you usually do in caring for your
. home or yard. Considering just those things that you do, please respond to (check) only
those statements that you are §.!!!!l describe yo~ today and are related to your state of
health.

1. I do work around tile house only for short
(117-054)

periods of time or rest often.

2. I am doing less of tile regular daily work
around the house than I would usuallydo .

---

(119-044)

----

(120-086)

---

(001-062)

3. I am not doingfillY of the regular dailywork
around the house that I would usually do.

4. I am not doing .!IIlYof the maintenanceor
repair work that I would usually do in my
home or yard.

w

5. I am not doing
would usually do .

of the shopping that I

6. I am not doing M!Yof the house cleaning
that I would usually do.

___

· (106-071)

---

(116-077)

---

(107-069)

'·

7 . I have difficulty doing handwork, for example,
turning faucets, using kitchen gadgets, sewing,
carpentry.

w

of the clothes washing that
8. I am not doing
I would usually do .

(111-077)

9. I am not doing heavy work around the house.

(115-044)

10. I have given up taking care of personal or
household business affairs, for example,
paying bills, banking, working on budget.

Che ck here when you have read all statements on this page

(105-084)

O
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(M-0719)
Please respond to (check) only those statements that you are!!!!!: describe you today
and are related to your state of health.

1. I am getting around only withinone building.

(134-086)

2. I stay within one room.

(128-106)

3. I am staying in bed more.

(130-081)

4. I am staying in bed most of the time.

(131-109)

5. I am not now using public transportation.

(140-041)

6. I stay home most of the time.

(133-066)

7. I am only going to places with restrooms
nearby.

(125-056)

8. I am not going into town.

(124-048)

9. I stay away from home only for brief periods
of ti.me.

(139-054)

10. I do not get around in the dark or in unlit
places without someone's help.

(121-072)

Ch~ck here when you have read all statements on this page

D
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This group of sutements has to do with activities you usually do in your free time.
These activities are things that you might do for relaxation, to pass the time, or for
entertainment.
Please respond to (check) .Q..!!!y
those statements that you are~
describe you today and are related to your state of health.

I.

I do my hobbies and recreation for shorter periods
of time.

(215-039)

(214-036)

2. 1 am going out for entertainment less often.

3.

I am cutting down on some of my usual inactive
recreation and pastimes, for example, watching TV,
playing cards, reading.

(207-059)

am not doing .fillYof my usual inactive recreation
and pastimes, for example, watching TV, playing

4. I

(208-084)

cards, reading.

5. I am doing more inactive pastimes in place of my
other usual activities.

(211-051)

6. I am doing fewer community activities.

(216-033)

7. I am cutting down on some of my usual physical

recreation or activities.

(210-043)

3. l am not doing my of my usual physical recreation

or activities.

Check here when you have read :iHst:icements on this page

(209-077)

D
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RIES
Instructions: Below is a list of comments made by people after they completed
treatment for breast cancer. Please circle the number which indicates how often
ea.ch of these comments was true for you in the past week.
0

= Not

at all

1

= Rarely

2 = Sometimes

3 = Often

1. I thought about it when I didn't mean to.

0

1

2

3

2. I avoided letting myself get upset when I thought
about it or was reminded of it

0

l

2

3

3. I tried to remove it from memory.

0

1

2

3

4. I had trouble falling asleep or staying asleep, because
of pictures or thoughts about it that came into my mind.

0

1

2

3

5. I had waves of strong feelings about it.

0

1

2

3

6. I bad dreams about it.

0

1

2

3

7. I stayed away from reminders of it

0

1

2

3

8. I felt as it hadn't happened or was not real.

0

1

2

3

9. I tried not to talk about it.

0

1

2

3

10. Pictures about it popped into my mind_

0

1

2

3

11. Other things kept making me think about it.

0

1

2

3

12. I was aware that I still bad a lot of feelings about
it , but I didn't deal with them.

0

1

2

3

13. I tried not to think about it.

0

2

3

14. Any reminder brought back feelings about it

0

2

3

15. My feelings about it were kind of numb.

0

2

3

1
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DIS
(baseline )

Since finding out you had cancer, how much have you disclosed your deepest thoughts
and feelings about having cancer and about your cancer treatment by talking, writing to
others, or writing in a journal? On a zero to 10 scale indicate the number that best
represents your responses to this question with zero being "not at all" and ten being
"c omplete disclosure ."
Not ~tall
0

2

3

4

5

6

7

·g

9

Completely
10
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